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ABSTRACT

Since the first antibiotics became widely available 60 years ago, they have been
used aggressively. However, bacterial infections continue to be significant clinical
problems both in hospital and community settings. Bacterial pathogens have become
increasingly resistant to a variety of antibiotics. They can acquire resistance genes, even
from distant related genera. Even the common resident (commensal) bacteria of the
human colon can carry and transfer antibiotic resistance elements to each other, or to
human pathogens. Bacteroides spp. organisms, the most predominant commensal bacteria
in the human gut, harbor a plethora of these elements, many of which are mobile
(transmissible); thus Bacteroides spp. are considered to be reservoirs of antibiotic
resistance genes. Mobile elements are transferred within and from the Bacteroides spp.
primarily by conjugation. One important approach to prevent the dissemination of
antibiotic resistance is to design drugs to disrupt the conjugation apparatus in the
Bacteroides spp. However, little is known about the molecular mechanism of this
machinery in Bacteroides spp.
Previously, our laboratory identified BTF-37, a 37kb conjugative transposon,
from the B. fragilis clinical isolate LV23. BTF-37 encodes conjugal apparatus proteins
and confers mobility to non-mobile plasmids. BctA, a highly conserved ORF on BTF-37,
xiv

encodes a potential coupling protein, the “gatekeeper” that couples transferring DNA
molecules to the membrane-associated conjugal apparatus. Studies from our laboratory
have shown that BctA is required for conjugation. One other gene on BTF-37 is orf7,
whose product ORF7 is also called TraM since it is a closely related homolog of a
previously identified, but unstudied putative conjugal apparatus protein harbored on the
transposon CTn341.
In this study, we demonstrated that TraM exhibits characteristics of a required
conjugal apparatus protein including 1) sequence conservation with other Bacteroides
spp. conjugal apparatus proteins; 2) upregulated expression under conjugation conditions;
3) localization to the bacterial inner membrane; 4) interaction with the putative coupling
protein BctA and the relaxase BmpH; and 5) absolute requirement for DNA transfer
within and from B. fragilis LV23. Sequence alignment, quantitative PCR, localization
studies, protein interaction studies and RNA antisense studies were performed to examine
the above characteristics. Moreover, mutagenesis and protein interaction studies revealed
that two amino acids (F66 and L123) in two predicted coiled-coil domains of TraM were
required for TraM interaction with BctA, suggesting that these two amino acids may be
essential for TraM function in mediating DNA transfer in B. fragilis. In addition, we also
identified a different amino acid, L123, as being important for the interaction of TraM
with the relaxase BmpH. These results suggest that there are likely complex mechanisms
involved in the interaction between TraM and BctA and/or BmpH, to facilitate DNA
transfer efficiently within and from B. fragilis.

xv

This study represents the first in-depth characterization of a conjugal apparatus
protein in B. fragilis, and will be useful for future studies aimed at developing
interventions to prevent dissemination of antibiotic resistance from Bacteroides spp. to
other bacteria. Moreover, this is one of very few studies using RNA antisense technology
to knock-down target gene expression in anaerobes, and has avoided the known difficulty
in genetically manipulating DNA in these organisms.

xvi

CHAPTER I
INTRODUCTION

One of the biggest battles that humans have ever faced is the battle against
infectious diseases. With rapid technology development, we thought that we could
conquer all diseases. However, no matter how technologies develop, microbes mutate
themselves to adapt and survive most treatments. In addition, they can also multiply
rapidly and transfer their adaptation characteristics to others. It is likely not efficient to
simply increase direct approaches to kill microbes. More efforts need to be focused on
other directions, specifically those designed to prevent microbial adaptation to treatments,
and to prevent the dissemination of adaptation traits amongst microbes.
One challenge that we encounter is the emergence and spread of bacteria that are
resistant to a broad range of “first-line” antibiotics (74, 75, 161, 170, 180). These include
bacterial infections that contribute most to human diseases: diarrhoeal diseases,
respiratory tract infections, meningitis, sexually transmitted infections, and hospitalacquired

infections.

Some

examples

include

penicillin-resistant

Streptococcus

pneumoniae, vancomycin-resistant enterococci, methicillin-resistant Staphylococcus
aureus, multi-resistant salmonellae, and multi-resistant Mycobacterium tuberculosis. The
consequences are severe. Treatments fail to treat infections caused by resistant bacteria,
1
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resulting in prolonged illness and greater risk of death. Treatment failures also lead to
longer periods of infectivity, which increase the numbers of infected people moving in
the community. As a consequence, the general population is exposed to the risk of
acquiring a resistant strain during infection. Moreover, when infections become resistant
to first-line antibiotics, treatment has to be switched to second- or third-line drugs, which
are much more expensive and sometimes more toxic. In many countries, this is also
unaffordable.

As a result, some diseases can no longer be treated in areas where

resistance to first-line drugs is widespread. Moreover, bacteria will finally adapt to resist
even the latest drugs. Humans may come to a point when no available drug can treat
certain diseases. Therefore, alternative approaches to prevent the dissemination of
antibiotic resistance elements are smart choices.
Bacteria are particularly efficient at disseminating the effects of resistance, partly
because they can transfer their resistance genes to others. Of immense concern, even
common resident (commensal) bacteria of the human colon can carry and transfer
antibiotic resistance elements to other bacteria, including human pathogens (189).
Moreover, the most predominant commensal bacteria of the gut, Bacteroides species
(spp.), are considered the reservoir of antibiotic resistance elements (151, 152, 161).
Nearly 100% of all Bacteroides spp. clinical isolates are now resistant to tetracycline
(126, 127). Many of them are resistant to β-lactam antibiotics (penicillin, ampicillin,
cephalosporins, cefoxitin, cephamycins and carbapenems), metronidazole and the
macrolide-lincosamide-streptogramin (MLS) group of antibiotics (erythromycin and
clindamycin) (161, 192). All of these resistant traits have been found on transmissible
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genetic elements (161). Over the past 3 decades, carriage of the tetracycline resistance
gene, tetQ, has increased from about 30% to nearly 100% of strains (161). The fact that
these resistance determinants are prevalent and found on transmissible elements in
Bacteroides spp., particularly conjugative transposons (161), raised the concern that
Bacteroides spp. may act as reservoirs of antibiotic resistance genes, which would then
be transferred to other bacterial species. The primary means for Bacteroides spp. to pass
on their resistance genes to other bacteria is "conjugation", whereby the genetic material
carrying antibiotic resistance genes is transferred from one bacterium to another (151,
192). It would be useful if we understood the conjugation machinery of Bacteroides spp.,
and designed preventions to disrupt the formation or action of the conjugation process.
This would help prevent the dissemination of antibiotic resistance genes in bacteria.
However, very little is known about the molecular mechanism of conjugation in
Bacteroides spp.
To gain deeper understanding of conjugation mechanism in Bacteroides spp., this
study focused on characterization of TraM, an important protein required for conjugation
in Bacteroides fragilis (B. fragilis), the most common anaerobic pathogen isolated in
human bacterial infections (62).
Conjugation involves two major sets of events: initiation (DNA processing) and
conjugal apparatus formation.
DNA processing includes binding, nicking and unwinding of the DNA,
independent of conjugal apparatus formation (89, 134). This process occurs via the
relaxosome, a nucleoprotein complex composed of specific proteins (mobilization
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proteins) covalently linked to the 5’ end of the DNA molecule to be transferred (133,
135). A relaxase, the major mobilization protein, nicks the DNA to be transferred at its
origin of transfer (oriT) (89, 134). This nicked DNA is unwound and transmitted in single
stranded copy with 5’-3’ polarity from the donor to the recipient (89). The passage from
the donor to the recipient occurs through a specialized membrane-traversing channel
called the conjugal apparatus.
The conjugal apparatus (CA) is a multi-protein channel that is assembled across
donor and recipient cell membranes during conjugation for DNA transferring (63, 154).
Although the formation of the conjugal apparatus is well studied in Agrobacterium
tumefaciens Ti plasmids and E. coli F and RP4 plasmids, little is known about its
structure and function in the Bacteroides spp. In E. coli and Agrobacterium tumefaciens,
this membrane channel is formed by 10-12 proteins (4, 63, 99, 100). In Agrobacterium
spp., each of these proteins has been extensively characterized (26, 29). However, the
Bacteroides spp. CA in even the best-studied elements is still poorly understood. To date,
the only detailed description of CA-encoding genes in Bacteroides spp. is from Smith
C.J. et al., who assessed the requirement of each CA gene of the CTn341 isolated from B.
vulgatus for DNA conjugation by creating deletion mutants (7).
Previously, our laboratory reported the capture of BTF-37, a 37kb conjugative
transposon, from a clinical B. fragilis isolate, LV23 (181). Due to A-T rich regions, only
16kb of BTF-37 was sequenced. This 16kb region carries 11 open reading frames
(ORFs). By sequence homology analysis with other Bacteroides known transfer factors,
and by RT-PCR studies, these 11 genes correspond to the transfer region of BTF-37 (77).
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In this work, RT-PCR studies showed that the transcripts of all of these 11 genes were
up-regulated when LV23 cells were stimulated with tetracycline. One of these 11 ORFs,
bctA, is an ORF highly conserved between different Bacteroides spp. transposons. BctA
encodes a putative coupling protein, the “gatekeeper” that couples transferring DNA
molecules to the membrane-associated conjugal apparatus, of BTF-37 CTn (77). We also
showed that BctA was required for transfer of BTF-37 (77).
BmpH is a relaxase encoded by the mobilizable transposon Tn5520 that was also
isolated from B. fragilis clinical isolate LV23 (182, 183). Studies from our laboratory
have shown that BmpH is a relaxase protein that is required for the formation and
function of the relaxosome, required for the mobility of Tn5520 (182).
We then identified ORF7, a Bacteroides spp. TraM homologous protein, as an
important conjugal apparatus protein. TraM is a 393 amino acid protein, and has 92%
sequence identity to TraM from B. fragilis NCTC9343, 61% sequence similarity to TraM
of B. fragilis YCH46 and 32% identity to TraM of B. thetaiotaomicron CTnDOT.
In this study, we demonstrated that TraM exhibits characteristics of a required
conjugal apparatus protein including 1) sequence conservation with other Bacteroides
spp. conjugal apparatus proteins; 2) upregulated expression under conjugation conditions;
3) localization to the bacterial inner membrane; 4) interaction with the putative coupling
protein BctA and the relaxase BmpH; and 5) requirement for DNA transfer within and
from B. fragilis LV23. Sequence alignment, quantitative PCR, localization studies,
protein interaction studies and RNA antisense studies were performed to examine the
above characteristics. Moreover, mutagenesis and protein interaction studies revealed that
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two amino acids (F66 and L123) in two predicted coiled-coil domains of TraM were
required for TraM interaction with BctA, suggesting that these two amino acids may be
essential for TraM function in mediating DNA transfer in B. fragilis. We also identified
another amino acid, L123, as being important for the interaction of TraM with the
relaxase BmpH.
This study represents the first in depth characterization of a conjugal apparatus
protein in B. fragilis, which will be useful for future studies aimed at developing
interventions to prevent dissemination of antibiotic resistance from Bacteroides spp. to
other bacteria. Moreover, this is one of very few studies using RNA antisense technology
to knock-down target gene expression in anaerobes, avoiding the difficulty in modifying
genes in these genera.

7

Figure 1. Bacteroides relaxosome and conjugal apparatus structural model, based on
studies in E. coli. Adapted from Christie, Nature, 2009 (28).

CHAPTER II
LITERATURE REVIEW

Antibiotics and Antibiotic Resistance

Antibiotics are drugs that act to kill bacteria or to inhibit their growth. For
thousands of years, many ancient cultures (Chinese, Greek, Egyptians) used plants or
molds with antimicrobial properties to treat infections. However, it was not until early in
the twentieth century that natural antibiotics produced by microorganisms were
discovered. In 1928, the British microbiologist Sir Alexander Fleming made a chance
discovery of the first antibiotic, penicillin, from the common bread mold Penicillium
growing on a culture of Staphylococcus aureus (187). By the 1940s, penicillin was
available for medical use and was successfully used to treat infections in soldiers during
the World War II. Penicillin has since been commonly used to treat a wide range of
infections including ulcers, diphtheria, gonorrhea, meningitis, pneumonia, syphilis and
tuberculosis (8). Since then, many more antibiotics have been isolated from fungi (molds)
and bacteria. One group of bacteria, the Streptomyces, produces most of the medically
important antibiotics, such as quinolones, spectinomycin, tetracycline, and streptomycin
(186). Moreover, with the development of medical chemistry, many semi-synthetic and
8
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novel synthetic antibiotics were also introduced into clinical practice (162). It has been
estimated in 2002 that 100,000- 200,000 tons per annum, and, a total of more than one
million tons of antibiotics have been applied worldwide in human and animals since the
1940s (194).
Antibiotics can be classified based on their mode of action, structure or spectrum
of activity. They can be bactericidal (kill susceptible bacteria), or bacteriostatic (inhibit
bacterial growth). Most antibiotics target bacterial functions or growth processes. They
can target the bacterial cell wall (penicillins, cephalosporins), cell membrane
(polymixins), protein synthesis (the aminoglycosides, macrolides, and tetracyclines), and
nucleic acid synthesis and function (rifampicin, quinolones) (46). Narrow-spectrum
antibiotics target particular types of bacteria, such as Gram-negative or Gram-positive
bacteria, while broad-spectrum antibiotics affect a wide range of bacteria.
The extreme efficiency of antibiotics in clearing bacteria led many to believe that
infectious diseases would be completely wiped out. However, the golden age of
antibiotics did not last long. During the past few decades, many strains of bacteria have
evolved and disseminated resistance to antibiotics. Just a few years after the mass
introduction of penicillin, i.e., by 1950, 40% of hospital Staphylococcus aureus isolates
were penicillin resistant; and by 1960, this had risen to 80% (24). In 1980, it was
estimated that 3-5% of Streptococus pneumoniae were penicillin resistant and 34% of S.
pneumoniae samples were resistant to penicillin (41). Antibiotic resistance by other
organisms reflects the same trend. Tetracyline was introduced in the 1950s and quickly
became one of the most widely prescribed broad-spectrum antibiotics. However,
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tetracycline resistance by normal human intestinal flora has exploded from 2% in the
1950s to 80% in the 1990s (161). Kanamycin, an antibiotic used in the 1950s, has
become clinically useless due to the abundance of kanamycin resistant bacteria.
Dangerously, the emergence of many strains of multidrug resistant bacteria has become a
major clinical problem, complicating the treatment of bacterial infections and leading to
increased mortality (39, 112, 117, 152). Many strains of Staphylococcus aureus, a major
cause of deadly infections in hospitals, are already resistant to all antibiotics except the
reliable vancomycin. However, over the last few years, vancomycin-resistant strains have
also emerged (25). Multidrug resistant strains of Mycobacterium tuberculosis, the
causative agent of tuberculosis - that kills 1.7 million people annually - are also spreading
all over the world (117).
How do we overcome the problem of antibiotic resistance? Obviously, increasing
the direct combative approach may not be a good choice as bacteria may quickly evolve
to surpass new generations of antibiotics. Even when the use of antibiotics is restricted,
the incidence of antibiotic resistance is reduced, but never disappears (53, 55). Therefore,
alternative approaches to prevent the dissemination of antibiotics resistant elements are
smart choices.
It has been known that antibiotic resistant bacteria have evolved to acquire many
mechanisms to resist antibiotics, such as reduction of cell permeability to antibiotics,
increase efflux of antibiotics, alteration of the antibiotic target site, enzymatic
inactivation of antibiotics, alteration of metabolic synthesis to bypass the inhibited
reaction of antibiotics, and overproduction of antibiotic targets (39, 170). These
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mechanisms can be acquired through spontaneous mutation. However, in the majority of
cases, acquisition from exogenous sources is the primary mechanism by which bacteria
obtain genes encoding resistance to antibiotics (39). In these cases, the acquisition of
genes encoding antibiotic resistance occurs mainly through horizontal gene transfer
mechanisms: transduction (acquisition from a bacteriophage), transformation (acquisition
from free DNA from and conjugation (acquisition from another bacterium through a cellcell contact). Among these methods, conjugation is by far the most widespread, and most
efficient. Therefore, a deeper understanding of horizontal gene transfer, especially
conjugation mechanisms, may help in designing interventions to prevent antibiotic
resistance dissemination in bacteria.
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Figure 2: Mechanism of resistance acquisition. DNA encoding an antibiotic resistance
gene (red) can be transferred by horizontal gene transfer into a recipient by several paths:
cell-to-cell conjugation; transformation by naked DNA (on plasmids or as linear DNA)
that is released by dead cells; or phage-mediated transduction. Resistance can also arise

13
by de novo mutation (indicated as a red cross). (Adapted from Andersson et al. Nat Rev
Microbiol, 2010 (3)).

Bacteroides spp, from Commensals to Pathogens

It has been estimated that microbes in our bodies collectively make up to 100
trillion cells, tenfold the number of human cells (96, 197). Moreover, the number of
genes in our microbiome is more than 100 times the number of human genes, making us
genetically 1% human and 99% bacteria (169, 197). The majority of these normal flora,
with over 500 bacterial species, 1011 organisms per gram of wet weight, reside in the gut,
have a profound influence on human physiology and nutrition, and are crucial for human
life (110). Of these, 99% are anaerobes (65). The anaerobic Bacteroides spp. are the most
predominant species, accounting about 30% of all bacteria in the human gut (149, 189).
Bacteroides spp. are bile-resistant, non-spore forming, gram-negative, rod-shaped
anaerobes that are the most predominant bacterial species in the human colon and are less
abundant in the intestines of other animals and in the environment (161, 192). The genus
comprises more than 20 species, of which B. fragilis is the most frequent isolate from
clinical specimens (189). Bacteroides sp are passed from mother to child during vaginal
birth and thus become part of the human flora in the earliest stages of life (145). The C+G
nucleotide composition of Bacteroides genome is in the range of 40-48%. Its membranes
contain sphingolipids, which is unusual in bacteria.
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Bacteroides spp. as Gut Commensals
As part of the human gut normal flora, Bacteroides spp. play a number of
commensal roles, such as providing energy for the host in the form of short fatty acids
and sugars, being involved in the recycling of bile acids and aiding in the development of
the host immune system (189). They also exhibit unique adaptations to successfully
colonize the gut such as the ability to change their cell surface architecture, ability to
stimulate host expression of fucosylated glycoproteins and synthesize them, and the
ability to tolerate and use oxygen.
Bacteroides spp. provide energy for the host in the form of fatty acids and sugars.
Bacteroides spp. and other intestinal bacteria ferment carbohydrates to produce a pool of
volatile fatty acids, predominately acetate, propionate (from succinate), and butyrate, that
can be easily reabsorbed through the large intestine and utilized by the host as an energy
source (81). Studies show that germ-free rats lacking gut flora need 30% more calories to
maintain body mass than normal rats (56). Bacteroides can also generate sugars via their
glycosylhydrolases; this benefits not just the host but also other organisms that do not
have such sugar utilization enzymes. B. thetaiotaomicron has an extensive starch
utilization system and multiple genes (sus genes) that are involved in starch binding and
utilization (198). B. thetaiotaomicron contains more glycosylhydralases than any
sequenced prokaryote and appears to be able to cleave most of the glycosidic bonds
found in nature (197). Encoding 172 glycohydrolases and 163 homologs of starch
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binding proteins, they can utilize the wide variety of dietary carbohydrates that might be
available in the gut (196, 198).
In addition, Bacteroides spp. also play a key role in the recycling of bile acids.
Before secretion in bile, bile acids are synthesized in the human liver, conjugated to
taurine or glycine polar side groups. These conjugated forms help bile assist in absorption
of dietary fats in the upper intestine. If bile acids are not used, they are deconjugated by
bacteria to re-enter the enterohepatic circulation, return to the liver and re-conjugated for
further use (15). Containing many enzymes required for these reactions, including a
hydrolase, dehydrogenase, and dehydroxylase, Bacteroides spp. are known to play a
major role in the deconjugation of bile acids (116).
Moreover, during mammalian development, Bacteroides spp. stimulate intestinal
angiogenesis and induce local and systemic immune function (80, 82, 114). Intestinal
bacteria are important in the development of gut-associated lymphoid tissue (GALT).
Without bacterial colonization in the gut, the development of GALT is defective (80). In
rabbits, B. fragilis and Bacillus substilis promote development of GALT and the preimmune antibody repertoire (147). In addition, it has been shown that in newborn mice,
B. thetaiotaomicron promotes angiogenesis and postnatal development (171). The gut
epithelium undergoes constant renewal throughout the postnatal period. The appearance
of Paneth cells, a lineage of stem cells and a key cellular component of the innate
immune system, coincides with initial colonization of the gut and their subsequent
differentiation is influenced by the gut microbiota, (6, 20). B. thetaiotaomicron can
stimulate production of an antimicribial Paneth cell protein (Ang4) that can kill certain
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pathogens (171). Moreover, zwitterionic polysaccharides (ZPS) produced by B. fragilis
have been shown to be important in the activation of CD4+ T cells and appear to be
involved in the development of CD4+ T cells (113).
As the most predominant bacteria residing in the gut, Bacteroides spp. have
several unique adaptations allowing them to successfully survive in this niche. They can
rapidly change their cell surface architecture through the production of an unusually large
number of phase-variable capsular polysaccharides (87), an adaptation that appears
specific to the intestinal environment (33). This surface-altering capability is most
developed in B. fragilis, which is more frequently found at the mucosal surface, the site
of attack by host defense (88). Also, Bacteroides fragilis has been shown to stimulate
expression of fucosylated glycoconjugates on the intestinal epithelia of colonized mice
(21). Bacteroides spp. produce enzymes to harvest fucose from host mucosal glycans and
have a rare bacterial pathway to incorporate this exogenous fucose directly into capsular
polysaccharides and glycoproteins (35). It is suggested that the ability of B. fragilis to
synthesize fucosylated glycoproteins is essential for its competitive colonization in the
mammalian intestine (32, 35). Finally, the ability of B. fragilis to tolerate and use oxygen
may partly explain the observation that it is mostly found at the mucosal surface, where
oxygen tensions are higher than within the intestinal lumen (12).

Bacteroides spp., Commensals Gone Bad Pathogens
As discussed above, Bacteroides spp. are normally commensals in the gut.
However, when they escape the gut due to surgery or other trauma, they can cause life-
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threatening infections such as peritonitis and intra-abdominal sepsis (161, 185, 189).
Intra-abdominal sepsis is the most common infection caused by Bacteroides spp.
Following the disruption of the intestinal wall due to a surgical wound, malignancies, or
appendicitis, the gut flora spill out and infect the normally sterile peritoneal cavity. At
first, the aerobes, such as E. coli, dominate the infection site, reducing the oxidationreduction potential of the oxygenated tissue. Once sufficient oxygen has been removed,
anaerobic Bacteroides spp. replicate and predominate during the second, chronic stage of
infection (189). Bacteroides spp. rarely cause endocarditis, inflammation of the inner
layer of the heart, but when it occurs it can be serious with a mortality rate of 21-43%
(19). They can also be found in other infections such as skin and soft tissue infections,
bacteremia, septic arthritis, brain abscess and meningitis (189). Enterotoxigenic
Bacteroides fragilis (ETBF), a sub-group of B. fragilis also has been implicated in
inflammatory bowel disease (IBD) (10, 140) and colon cancer (176).
Although B. fragilis accounts for only 1-2% of the human intestinal flora, it is the
most commonly isolated anaerobic pathogen, partly due to its virulence factors including
surface polysaccharide capsules, outer membrane vesicles, toxins and β-lactamase (139).
In addition, the capacity of B. fragilis to tolerate nanomolar concentrations of oxygen
allows this species to predominate in infections in peritoneal cavity.
B. fragilis expresses the most number of distinct capsular polysaccharides (at least
eight). The Bacteroides capsule has an unusual structure, composed of repeating units of
two distinct high molecular weight polysaccharides, each of which contains exposed
positively and negatively charged side-chains (179). This zwitterionic motif is critical for
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promoting the formation of abscesses (179). Injection of capsules alone has proven
sufficient to induce abscess formation in rats (34). Capsule also can resist to complementmediated killing and to phagocytic uptake and killing (54, 146).
In addition, B. fragilis produces numerous outer membrane vesicles (OMVs).
These vesicles have been shown to have haemagglutin function and sialidase activity.
Neuraminidase activity in OMVs was correlated to virulence (42). Moreover, OMVs can
carry endotoxins to target cells.
Moreover, B. fragilis may secrete two toxins: endotoxin (LPS) and B. fragilis
enterotoxin (named BFT or fragilysin). BFT is a 20kD zinc-dependent metalloprotease,
secreted by enterotoxigenic B. fragilis. ETBF causes acute inflammatory diarrheal
disease in children and adults (157). BFT mediates proteolytic cleavage of the
extracellular domain of the adherent protein, E-cadherin, which is a cell-surface protein
of epithelial cells (195). Higher ETBF colonization levels have also been found in
individuals with colon cancer relative to others without colon cancer, suggesting that
EBTF may be involved in development of colon cancer (176).
Most Bacteroides strains express constitutive β-lactamase activity. β-lactamase
enzyme is extra-cellular, and thus is capable of diffusing within an abscess or other site of
infection. Production of extra-cellular β-lactamases has been shown to protect other
organisms in the vicinity during a mixed infection (129).
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Figure 3. Proportions of Bacteroides species observed from clinical isolations.
Adapted from Wexler, Clin Microbiol Rev, 2007. (189).
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Bacteroides spp. and Antibotic Resistance
Many Bacteroides spp. are resistant to aminoglycosides (gentamicin, kanamycin,
streptomycin), tetracycline (nearly 85% of clinical isolates), β-lactam antibiotics
(penicillin, ampicillin, cephalosporins, cefoxitin, cephamycins and carbapenems),
metronidazole and the macrolide-lincosamide-streptogramin (MLS) group of antibiotics
(erythromycin and clindamycin) (161, 192). All of these resistance traits have been found
on transmissible genetic elements (161). Over the past 3 decades, carriage of the
tetracycline resistance gene, tetQ, has increased from about 30% to more than 80% in
clinical strains (161). The fact that these resistance determinants are prevalent and found
on transmissible elements in Bacteroides spp., particularly conjugative transposons (161),
is of particular concern. The concern is not only that opportunistic infections caused by
Bacteroides spp. may become untreatable, but also that Bacteroides spp., as reservoirs of
antibiotic resistance genes, may then transfer them to other bacterial species.
The mechanism responsible for the dissemination of genetic elements in
Bacteroides spp. is conjugation, one of the most important mechanisms of horizontal
gene transfer in prokaryotes. However, the molecular structure and mechanism of this
process is poorly understood in Bacteroides spp.

Bacterial Conjugation
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Conjugation, a subset of the bacterial type IV secretion system (T4SS), is defined
as the unidirectional transfer of single-stranded DNA molecule from a bacterial donor
cell to a recipient cell, in a process requiring cell-to-cell contact (193). During
conjugation, one copy of the DNA strand is transferred to, and replicated in, the recipient
cell. The parent DNA is retained and replicated in the donor cell. Transfer DNA
molecules, which can be either plasmids or transposons, are of two types: conjugative
and mobilizable. Conjugative plasmids and transposons are self-transmissible elements.
They encode all of the components necessary for transfer. Mobilizable plasmids and
transposons are non-self-transmissible elements. Their transfers require the assistance of
a co-resident conjugative transfer element. Conjugative elements tend to be large
(>30kb), while mobilizable elements are small (<15kb) (50). Conjugative plasmids tend
to have low copy number, while mobilizable plasmids tend to have high copy number
(50).
All transfer elements contain a cis-acting origin of transfer (oriT), where transfer
is initiated. The oriTs are specific sequences, about 30 to 500 bp, significantly located
adjacent to the transfer initiation genes known as mobilization (“mob”) genes to form a
compact mobilization region (89). A common feature of the oriT is the presence of
inverted repeats adjacent to the sequence where nicking of DNA occurs (132). The nick
(nic) site, a short stretch of about 10 nucleotides is the site for recognition by a relaxase,
an enzyme required for the nicking of the transfer DNA in the initiation process.
Conjugation involves two major sets of events: Initiation (DNA processing) and
conjugal apparatus formation.
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Initiation (DNA processing)
DNA processing includes binding, nicking and unwinding of the DNA,
independent of conjugal apparatus formation (89, 134). This process occurs via the
relaxosome, a nucleoprotein complex composed of specific proteins (mobilization
proteins), one of which (relaxase) is covalently linked to the 5’ end of the DNA molecule
to be transferred (133, 135). The relaxase, the major mobilization protein, nicks the DNA
to be transferred in a site- and strand- specific manner at its origin of transfer (oriT) (89,
134), and then covalently associates with the 5’-end of the nicked DNA via a
phosphotyrosyl linkage. This nicked DNA is unwound and transmitted in single stranded
copy with 5’-3’ polarity from the donor to the recipient (89). Single-stranded copies in
both the donor and the recipient are then re-circularized and made double stranded (89).
The passage from the donor to the recipient occurs through a specialized membrane
traversing channel called the conjugal apparatus.
Relaxase proteins, the major mobilization proteins of the relaxosomes, are large
and usually contain two or more proteins domains. The relaxase domain is always located
at the N-terminus of the protein (50). At the C terminus, a DNA helicase, DNA primase
or other domain of unknown function is almost always found (50). Crystal structures of
some relaxases have been established, including, the relaxase domain of TraI from F
plasmid with and without a bound DNA substrate (90, 91), the relaxase domain of TrwC
from plasmid R388 with bound DNA (13, 66) and the relaxase domain of MobA from
IncQ plasmid R1162 (121). In many cases, the relaxase domain contains at least three
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conserved protein motifs. Motifs I contains the active site tyrosine, which creates a
single-stranded 5’ DNA nick through a trans-esterification reaction similar to type I
topoisomerase (134). This reaction involves the nucleophilic attack on the DNAphosphate backbone by the tyrosine’s hydroxyl group, resulting in a reversible covalent
phosphodiester bond (23, 89). Motif II might be responsible for the recognition and
noncovalent binding of the relaxase with the end of the trailing region 3’ of the nic site.
Motif III is histidine-rich and is called HUH (His-hyrophobic residue-His) or HHH (HisHis-His). This motif may facilitate the cleavage reaction (trans-esterification) by
abstracting a proton from the terminal tyrosine hydroxyl, allowing the oxygen to act as a
nucleophile (89). The termination of strand transfer occurs via a second cleavage
reaction, releasing a single-stranded DNA molecule in the recipient cell (89).
Most relaxases require assistance from accessory proteins to bend and change the
conformation of the DNA to facilitate relaxase binding. The RP4 E. coli plasmid encoded
relaxosome requires three proteins (two cognate proteins and a host encoded integration
host factor-IHF) for correct conformational DNA bending, which helps the relaxase to
easily bind and nick the DNA (23). Similarly, relaxase activity of the TrwC relaxase of
the R388 plasmid system also requires assistance from TrwA (120). In the F plasmid
system, TraY also enhances the relaxase/helicase activity of TraI (108).
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Figure 4. Scheme of the relaxase domain of a relaxase. The three conserved motifs are
represented by red (I), purple (II) or orange (III) boxes.

Figure 5. Depicted catalytic activities of a relaxase. (1) The relaxase with relaxase
domain in blue and helicase domain in red recognizes an extruded cruciform at oriT. (2)
The binding results in DNA melting and cleavage of the T-strand. (3) The end 3’ to nic
remains covalently bound to the catalytic tyrosine while the protein moves in the 5’ to 3’
direction unwinding the DNA. The uncleaved strand serves as a template for
complementary strand synthesis (orange) by host DNA polymerase. (4) The relaxase
reaches the regenerated oriT DNA and again recognizes the specific nic sequence. (5) A
second cleavage occurs followed by a strand-transfer reaction that (6) produces a
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circularized T-strand DNA (in blue) that will be transferred to the recipient cell. Adapted
from Guasch et al., Nature structural biology, 2003 (66).

Conjugal Apparatus
The second process in conjugation is the formation of the conjugal mating
apparatus. The conjugal apparatus (CA) is a multi-protein channel that is assembled
across donor and recipient cell membranes during conjugation for DNA transferring (63,
154). In addition, there is often a pilus or other surface filament or proteins(s) associated
with the core complex to facilitate adhesion and contact between two cells (30, 31).
Although the formation of the conjugal apparatus is well studied in
Agrobacterium tumefaciens Ti plasmids and E.coli F, RP4 and R388 plasmids, little is
known about its structure and function in Bacteroides spp. In E. coli and A. tumefaciens,
this membrane channel is formed by 10-12 proteins (4, 63, 99, 100). In E. coli RP4
plasmid system, the mating channel is composed of 10 mating pair gene products, a TraF
pilin support protein and the coupling protein TraG (63, 71). In E. coli F plasmid system,
that channel is composed of 11 proteins including the coupling protein TraD (93). In A.
tumefaciens, each of these 12 proteins named VirB1 to VirB11 and VirD4 has been
extensively characterized (26, 29). Recently, a cryo-electron microsopy (cryo-EM)
structure of the core complex of the conjugal apparatus encoded by the E. coli
conjugative plasmid pKM101 showed that the CA complex is 108 Ansgtrom wide and
high and spans from the inner to outer membranes (48). However, in Bacteroides spp.
CA in even the best studied element is still poorly understood. To date, the only detailed
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description of CA-encoding genes in Bacteroides spp. is from the laboratory of Smith
C.J. et al., who assessed the requirement of each CA gene of the CTn341 isolated from B.
vulgatus for DNA conjugation by creating deletion mutants (7).
Studies from T4SS in A. tumefaciens VirB/D4 system suggested four stages
required for the formation of the CA (30).
•

Stage I: Formation of the core complex. In this stage, a stable structure, termed a
core complex, composed of several highly conserved proteins, assembles across
the cell envelope. In A. tumefaciens, the core complex is composed of five highly
conserved proteins. The existence of this core complex is demonstrated by
interactions among these proteins (30). There is indirect evidence that this core
substructure alone confers function. During conjugation between A. tumefaciens
donor and recipient cells, synthesis of core subunits in the recipient cells
stimulates acquisition of DNA by several orders of magnitude (14, 102).
Similarly, in Helicobacter pylori, homologs of A. tumefaciens core complex
assemble as a competence system (79).

•

Stage II: Recruitment of pilus-associated proteins. In the stage II reaction, the
core complex recruits subunits required for trans-membrane pilus assembly. In A.
tumefaciens, the production of the stage II subunits stimulates DNA transfer to a
greater extent than does synthesis only of the core components (102).

•

Stage III: Recruitment of an ATPase to the inner membrane. It is proposed that
the ATPase stimulates formation of trans-envelope structures composed of an
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inner membrane platform, a polymer that extends across the periplasm, and an
outer membrane pore complex (104).
•

Stage IV: Modifications to yield the pilus or secretion channel. In this stage, the
pilus may undergo depolymerization to facilitate close cell-to-cell contact. The
mating apparatus may also undergo conformational changes to become fully
functional (30).
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Figure 6. Biogenesis pathway of the A. tumefaciens VirB/D4 T4SS. A four-stage
assembly pathway is presented. Stage I: assembly of the core complex; Stage II:
Recruitment of pilus associated components (B2, B3, B5). Stage III: Recruitment of
ATPase. Stage IV: Formation of T-pilus or DNA secretion channel. Adapted from
Christie et al., Annu. Rev. Mirobiol., 2005.

Table 1. Comparison of conjugal apparatus of different A. tumefacien, E. coli and Bacteroides spp. mating systems.

Mating system

Number of CA
proteinsa

A. tumefaciens

12

VirB/D system (2)

Energetic
componentsb

Core channel components

VirD4 (CP),

VirB3, VirB8, VirB10,

VirB11, VirB4

VirB6, VirB7, VirB9, VirB1

12

plasmid (63)

TraG (CP)

11

(93)

TraD (CP), TraC

TrbF, TrbG, TrbH, TrbI, TrbJ, TraF

B. thetaoimicron

17 putative

Putative CP: TraG

CTnDOT (161)

gene products

(OrfG)

N/A.

Putative CP: BctA
(77)

B. vulgatus

17 putative

Putative CP: TraG

CTn341 (7)

gene products

(OrfG)

TraL, TraE, TraK, TraB,

Specific for
own cognate
relaxosome
Yes (73)
Yes (to closely

TrbL

E. coli F factor

(181)

VirB2, VirB5

TrbB, TrbC, TrbD, TrbE,

E. coli RP4

B. fragilis BTF37

Pilus
components

related plasmids)
(73)

TraA

Yes (155)

N/A

N/A

No

ORF7 (TraM), ORF8 (TraN)c

N/A

No

N/A

N/A

No

TraV, TraG, TraW, TrbC,

a

: Number of CA proteins includes energetic components, core channel components and pilus components.b: Energetic

components include coupling protein and other ATPase proteins. c. This study.
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Coupling Protein
One of the CA’s important components is the coupling protein (CP). CPs are
present in all conjugative plasmids or transposons. No CP is encoded in any mobilizable
elements. The CP is unique to conjugation and is considered the first point of contact that
the relaxosome and/or transfer DNA makes with the CA. The best characterized CPs are
protein TrwB of plasmid R388 (IncW group), TraD of F plasmids (IncF group), TraG of
RP4 plasmids (IncP group), and VirD4 of A. tumefaciencs Ti plasmids (61). These
proteins share the following characteristics:
1. CPs are not involved in DNA processing events or in pilus production. They are
needed after pilus assembly and contact formation. For example, traD mutants of
plasmid F prevent DNA transport to the recipient cell, but not its initiation in the
donor cell (86).
2. CPs are composed of transmembrane α-helices in their N-terminal region that
mediate anchoring to the inner membrane. Indeed, they are integral inner
membrane proteins (103, 119, 131). They also typically have a main cytoplasmic
C-terminal domain (38, 63, 94, 103). Thus, their location is the link between a
cytoplasmic system and the membrane complex CA.
3. CPs have a nucleotide binding motif, and in fact, can bind both single- and
double-stranded DNA nonspecifically, suggesting a specific role in DNA transfer
(119).
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4. A CP has a Walker box domain (an ATP hydrolysis motif), and some other
cytoplasmic domains that interact with the relaxosome (141). No ATPase activity
has been reported so far, but the presence of Walker box motifs suggest that CPs
use ATP hydrolysis as an energy source to work as motors. It is speculated that
when CP interacts with the relaxosome, the Walker-box mediates ATP hydrolysis
to provide energy to “pump” the relaxosome through the CA and into the
recipient cell (104, 175). With this role, CPs are considered “gatekeepers” of
conjugation. The A. tumefaciens CA has two of these CP “gatekeepers”, VirD4
and its required partner VirB4, both of which have nucleotide binding activity
(44, 115, 141). However, in E. coli, only one CP has been described for each
conjugative system.
5. CPs are often multimeric proteins. The 3D crystal structure of the soluble
cytoplasmic domain of TrwB, the CP of the IncW plasmid R388, shows that it is a
hexameric protein, resembles a ring helicases (60).
Most importantly, in many transfer systems, including those elaborated by the E.
coli F plasmids and A. tumefaciens Ti plasmids, their CPs are highly selective for the
respective relaxosome to be transferred (73, 155). However, in B. fragilis, the putative
CPs seem not selective for the relaxosome. Many different conjugative transposons and
mobile elements even from different origins can be transferred from B. fragilis to bacteria
from other genus, such as E. coli. This is one reason explaining why Bacteroides spp. are
considered as reservoirs for transferring antibiotic resistance elements to other bacteria.
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Figure 7. Conjugation. Conjugation systems represent a large subfamily of the T4SSs
and are used by bacteria in the process of the conjugative transfer of DNA from donor to
recipient cells. A) cell-to-cell contact usually by the retraction of the pilus-like structures
(B). C. ssDNA of the mobile genetic element is transferred from the donor to recipient
bacteria with the help of the relaxase. D. Complementary DNA strands are synthesized in
both cells and the former recipient becomes a new potential donor of the mobile DNA.
Adapted from Juhas et al., Microreview, 2008 (85).
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Bacteroides spp. Conjugation

Mobile Genetic Elements in Bacteroides
Bacteroides spp. harbor many conjugative and mobilizable elements, which can
be transposons or plasmids. A significant proportion of these carries antibiotic resistance
genes and is critically important in the spead of antibiotic resistance genes.

Table 2: Summary of mobile genetic elements found in Bacteroides spp.
I. Conjugative elements

II. Mobilizable elements

Self-transmissible

Need help for transfer

Process DNA for transfer

Process DNA for transfer

Encode mating channel (CA) for completely

Depend on mating channel formed by

autonomous transfer

co-resident conjugative elements

Many carry many antibiotic resistance genes
I.a. Conjugative plasmids:

II. a. Mobilizable plasmids:

Have oriT and trans-acting mobilization gene
Can replicate independently
Some can integrate into the recipient chromosome
Examples: pBF4 (159), pBI136 (164)

Examples: pBTM10 (168)

I. b. Conjugative transposons:

II. b. Mobilizable transposons:
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Located on chromosome
Do not replicate independently
52 kb to 150 kb

Much smaller

Are referred to as Tet elements since most
of them carry the tetracycline resistance
gene tetQ.
Examples: BTF-37 (181), CTnDOT (16),

Examples: Tn4399 (78), Tn5520

CTnERL (17), Tcr Emr DOT (97), Tcr Emr

(183), cLV25 (9), NBU1, NBU2

7853 (127), CTnBST (70), CTnGERM1

(98), Tn4555 (166)

(184), CTn86 (22) and CTn9343 (22).

Plasmids. Plasmids are very common in Bacteroides spp. and are found in 20 to
50% of strains (189). Almost all plasmids can replicate as independent elements in host
cells, and some can integrate into the host chromosome (153). Many plasmids have oriT
and a trans-acting mobilization gene, which allow them to be transferred by conjugation
(189).
Genes resistant to many antibiotics have been found in plasmids in Bacteroides
spp. Genes resistant to metronidazole, chloramphenicol, carbapnems, clindamycin and
erythromycin have been found in mobile plasmids in Bacteroides spp. worldwide.
Resistance genes nimA - nimF, encode metronidazole resistance, have been identified on
transferrable plasmids and observed in several cases worldwide (106). The cfiA gene,
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conferring resistance to carbapenems, has also been found on a plasmid in clinical
isolates (124).
To date, two conjugative plasmids have been identified: the B. fragilis 41 kb
pBF4 plasmid and B. ovatus 80.6 kb pBI136 plasmid. Sequence analysis of the transfer
regions of these plasmids have been limited due to A-T rich sequence properties. Only
one gene, bctA, encoding a putative 110 kD protein that localizes to the membrane, has
been characterized as being required in mating process (123). There are also other
mobilizable plasmids that can only be transferred via mating channel formed by other coresidant conjugative elements, such as B. fragilis BFTM10 (168).

Transposons. Transposons, both mobilizable and conjugative, are located on the
chromosome and do not replicate independently. They excise from and integrate into
chromosomal DNA and are copied along with the chromosomal DNA.
Mobilizable transposons, like mobilizable plasmids, cannot self-transfer but can
transfer from bacterium to bacterium in the presence of the helper element (189).
Mobilizable transposons are much smaller than conjugative transposons and carry genes
required for excision, mobilization and integration. However, they do not encode the
conjugal apparatus components and have to rely their transfer on other co-resident
conjugal elements like conjugative transposons. Some identified mobilizable transposons
are B. fragilis 3.9 kb Tn4399 (78), B. fragilis 4.69 kb Tn5520 (183), B. fragilis 15.3 kb
cLV25 (9), B. uniformis 10.3 kb NBU1, B. uniformis 11.1 kb NBU2 (98) and B. vulgatus
12.5 kb Tn4555 (166).
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Conjugative transposons (CTn) are frequently found in Bacteroides spp. More
than 80% of Bacteroides strains contain at least one conjugative transposon (161).
Several conjugative transposons or tetracycline resistance factor (Tcr) ranging from 52 kb
to 150 kb have been identified in Bacteroides spp., including B. fragilis BTF-37 (37 kb)
(181), B. thetaiotaomicron CTnDOT (65 kb) (16), B. thetaiotaomicron CTnERL (52 kb)
(17), B. thetaiotaomicron Tcr Emr DOT (70 kb) (97), B. thetaiotaomicron Tcr Emr 7853
(70 kb) (127), B. thetaiotaomicron CTnBST (100 kb) (70), B. thetaiotaomicron
CTnGERM1 (75 kb) (184), B. vulgatus CTn341 (52 kb) (7), B. fragilis CTn86 (57 kb)
(22) and B. fragilis CTn9343 (64 kb) (22). Of these, CTnDOT (65 kb) from B.
thetaiotaomicron is the best described. CTns are also referred to as Tet elements since
most, but not all, carry the tetracycline resistance gene tetQ (153, 158). Tet elements also
carry the rteABC gene cluster involved in the regulation of Tet element conjugal transfer
(160, 173). rteA and rteB genes encode a tetracycline inducible two-component
regulatory system, which controls rteC expression (173). As a result, very low (sub
inhibitory) levels of tetracycline or its analogs with brief exposures can markedly elevate
conjugal transfer of Tet elements and other co-resident factors 1,000-to 10,000-fold (144,
160). Many B. fragilis conjugative transposons also carry erythromycin resistance genes
such as ermF (CTnDOT) (190), ermB (CTnBST) (188) or ermG (CTnGERM1) (184).
Conjugative transposons are mainly responsible for the spread of tetracycline and
erythromycin resistance in clinical isolates of Bacteroides spp (161). They are not only
responsible for the transfer of antibiotic resistance genes on itself but also for the transfer
of antibiotic resistance genes on other mobilizable elements. They are able to stimulate
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the excision and transfer of mobilizable transposons. The exact mechanism by which
conjugative transposons stimulate the excision and transfer of mobilizable transposons is
unknown. However, it is known that RteA and RteB encoded by genes located within the
central regulatory region of the CTnDOT/ERL family of conjugative transposons are
essential for the excision and mobilization of the NBUs mobilizable plasmids (172).
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Figure 8: Steps involved in the conjugal transfer of a conjugative transposon (192).
The integrated conjugative transposon (rectangle) excises from the chromosome of the
donor to form a covalently closed circular transfer intermediate in which the left and right
ends of the conjugative transposons are joined. A single-stranded nick is subsequently
made at the origin of transfer (oriT, black circle) in the circular intermediate, and the
nicked strand is presumably to be transferred from donor to recipient by a process similar
to conjugal transfer of plasmid DNA. In the donor and recipient, the single-stranded copy
of the conjugative transposon is replicated, yielding a double-stranded form of the
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conjugative transposon which then integrates in the donor and recipient chromosomes,
respectively. Adapted from Whittle et al., Cell Mol Life Sci, 2002.
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B. fragilis LV23, Conjugative Transposon BTF-37, Putative Coupling Protein
BctA and the Relaxase BmpH
Previously, our laboratory reported the capture of BTF-37, a 37kb conjugative
transposon, from a clinical B. fragilis isolate, LV23 (181). BTF-37 alone is capable of
facilitating transfer of DNA not only within the Bacteroides, but also from B. fragilis to
E. coli (181). Due to A-T rich regions, only 16kb of BTF-37 was sequenced. This 16kb
region carries 11 ORFs. By sequence homology analysis with other known Bacteroides
transfer factors, and by RT-PCT studies, these 11 genes likely correspond to the transfer
region of BTF-37 (77). Of these 11 ORFs, bctA is an ORF highly conserved between
different Bacteroides transposons.
bctA encodes a putative coupling protein of BTF-37 CTn (77). It is identical to the
putative coupling protein BctA of B. fragilis conjugative plasmid pBF4, 98% identical to
that of the B. fragilis NCTC9343, 74% to the B. fragilis YCH46 strain from Japan, and
48% to a BctA homolog from the B. fragilis CTnDOT conjugative transposon (77).
Computer analysis also reveals that BctA has two Walker-box-sequences as a
characteristic of a coupling protein. We also showed that BctA is a conjugal apparatus
protein required for transfer of BTF-37 (77). It has signal sequence required for
membrane localization, its expression is upregulated under conjugation conditions and
purified BctA migrated as a tetramer under non-denaturing PAGE.
BmpH is a relaxase encoded by the 4.6 kb mobilizable transposon Tn5520 that
was also isolated from B. fragilis clinical isolate LV23 (182, 183). Tn5520 carries only
two genes, that encode an integrase (bipH) and a mobilization protein (bmpH)
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respectively. Studies from our laboratory have shown that BmpH is a relaxase protein
that is required for the formation and function of the relaxosome, required for the
mobility of Tn5520 (182). BmpH alone is sufficient and required for DNA transfer of
Tn5520. It has been shown to be multifunctional, performing the specific recognition,
binding, and nicking of the oriT DNA (182).

The Search for Better Genetic Modification Tools in Anaerobes

To investigate protein function in a bacterial strain, it is important to generate a
knock-out (KO) strain to determine if a target protein is unable to perform a predicted
function. In B. fragilis and many other anaerobes like Clostridium spp., a traditional
method is to use a suicide vector to deliver a disrupted construct of the target gene from
E. coli to the recipient strain (32, 36). This method is based on integration of the altered
construct into the chromosome followed by screening for spontaneous resolution of the
diploid to yield the desired product (deletion of the target gene in the chromosome).
However, this method is time-consuming and problematic due to stringent recombination
barriers encountered in these genera (150). An alternative approach uses resistance to
trimethoprim, encoded by a chromosomal thyA mutation in B. fragilis, to select for
resolution of diploids where the suicide plasmid carries a functional copy of thyA (11).
Although this method helps resolve diploids, the strain to be engineered must be made
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trimethoprim resistant and all resulting strains contain a thyA mutation, which may have
undesirable consequences for further studies.
A recent study shows a new approach to delete a target gene in B. fragilis NCTC
9343 by using the I-SceI meganuclease to mediate double strand breakage, allowing
resolution of diploid (137). In essence, a suicide plasmid (pEP185.2), containing an ISceI recognition site, and sequences homologous to chromosomal DNA flanking an ermF
cassette and replacing the gene to be deleted is introduced into B. fragilis by conjugation,
and transconjugations are selected for resistance to erythromycin (137). Then, another
plasmid expressing I-SceI enzyme under the control of the fucose-inducible promoter
PfucR is transformed into the B. fragilis transconjugant. Under inducible condition, I-SceI
is expressed, induces breakage of double strand DNA at the I-SceI recognition site,
allowing resolution of the diploid to generate either the deletion or wild-type genotypes
by homologous recombination. However, this method has its own drawbacks. First,
it requires transformation to introduce the plasmid expressing I-SceI into B. fragilis cells,
which is known to be difficult to work with. Second, the suicide plasmid pEP185.2 is
tetracycline and erythromycin resistant, which is not useful for the selection of this
plasmid in clinical strains already tetracycline and erythromycin resistant like LV23.
Moreover, the presence of ermF in the suicide vector may allow plasmid incorporation
into ermF in the B. fragilis chromosome, not into the desired target gene.
Although not widely investigated in prokaryotic systems, antisense RNA
(asRNA) is a potent and flexible tool for manipulating microbial genetic. AsRNAs have
been successfully used to suppress the expression of bacterial proteins in several studies,
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especially in the clostridia (118, 125, 138, 143, 177, 178), where very similar difficulties
are encountered in generating knock-out mutants. Thus, although not has been tested in
B. fragilis this approach seems to be applicable in B. fragilis studies.

CHAPTER III
MATERIALS AND EXPERIMENTAL METHODS

Chemicals and Reagents

Chemicals and reagents used in this study were purchased from Sigma-Aldrich,
Inc. (St. Louis, MO), Fisher Scientific (Pittsburgh, PA) and Thermo Scientific (Waltham,
MA) unless otherwise mentioned.

Bacterial Strains and Plasmids
Bacterial Strains and plasmids used in this study are listed in Table 3 and 4.

Table 3. Bacterial strains used in this study
Strain

Relevant characteristic(s)a

Source or Reference

E. coli HB101

SmR

(18), Invitrogen

E. coli DH5α

recA1, endA1

(64), Invitrogen

E. coli XL-1Blue

recA1, endA1, KnR

Agilent Technologies

E. coli XL-1Blue MRF

TcR, Δ(mcrA)183 Δ(mcrCB-

Agilent Technologies
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hsdSMR-mrr)173 endA1 supE44
thi-1 recA1
KnR

Agilent Technologies

KnR

Agilent Technologies

E. coli BL-21AI

araB::T7RNAP, TcR

Invitrogen

B. fragilis LV23

TcR

Clinical isolate

B. fragilis TM4000

RfR

(163)

Bacteriomatch II
Reporter Cells
Bacteriomatch II
Validation Reporter
Competent Cells

B. fragilis TM4000

Hecht’s laboratory

BTF-37
a

: SmR, KnR, TcR, RfR indicate resistance to streptomycin, kanamycin, tetracycline and

rifampicin, respectively.

Table 4. Plasmids used in this study

Plasmid

Relevant characteristic(s)a

Source or Reference

BTF37

ApR ClnR TetXRTetR, ≈37-kb insert

(181)

in pGAT400ΔBglII
pGAT400ΔBglII

ApR ClnR TetXR

(76)
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RK231

KmR, E. coli broad-host-range R

(68)

plasmid
pQE30Xa

Protein expression vector with 6

Qiagen

Histidine tag and Factor XA
cleavage site, AmpR
pA8-Xa

Truncated bctA (lacking signal

(77)

sequence) cloned in pQE30Xa
p17-Xa

Full-length bmpH cloned in

(77)

pQE30Xa
pDEST42

Expression vector, Histidine and

Invitrogen

V5 C terminal tag, AmpR
p42M

Full-length traM cloned in

This study

pDEST42
pDEST24

Expression vector, Glutathione-S-

Invitrogen

transferase C terminal tag, AmpR
p24M

Full-length traM cloned in

This study

pDEST24
p24bmpH

pFD351

Full-length bmpH cloned in

S. Kralicek’s work in

pDEST24

the Hecht laboratory

Shuttle vector, ErmR, SpR, CcR

(136)

(Bacteroides sp.)
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pFD288

Shuttle vector, ErmR (CcR in B.

(167)

fragilis), SpR, (Bacteroides sp.)
pFD288P

PcfxA cloned in pFD288

This study

pFD288MAS1

traM-antisense AS1 cloned in

This study

pFD288P
pFD288MAS2

traM-antisense AS2 cloned in

This study

pFD288P
pFD288MAS3

traM-antisense AS3 cloned in

This study

pFD288P
pBT

Bait vector for bacterial two hybrid

Agilent Technologies

experiment
pTRG

Target vector for bacterial two

Agilent Technologies

hybrid experiment
pBT-LGF2

Positive control bait vector for

Agilent Technologies

bacterial two hybrid experiment
pTRG-Gal11

Positive control target vector for

Agilent Technologies

bacterial two hybrid experiment
pBT-M (pBT-ORF7)

Full-length traM cloned in bait

This study

vector, pBT
pBT-BctA

Full-length bctA cloned in bait
vector, pBT

This study
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pBT-BmpH

Full-length bmpH cloned in bait

This study

vector, pBT
pBT-ORF5

Full-length orf5 cloned in bait

This study

vector, pBT
pBT-ORF6

Full-length orf6 cloned in bait

This study

vector, pBT
pBT-ORF8

Full-length orf8 cloned in bait

This study

vector, pBT
pBT-M-F66A

traM mutation F66A in pBT vector

This study

pBT-M-F66G

traM mutation F66G in pBT vector

This study

pBT-M-F66R

traM mutation F66R in pBT vector

This study

pBT-M-L69A

traM mutation L69A in pBT vector

This study

pBT-M-L69G

traM mutation L69G in pBT vector

This study

pBT-M-L69R

traM mutation L69R in pBT vector

This study

pBT-M-L123A

traM mutation L123A in pBT

This study

vector
pBT-M-L123G

traM mutation L123G in pBT

This study

vector
pBT-M-L123S

traM mutation L123S in pBT

This study

vector
pBT-M-L123R

traM mutation M123R in pBT

This study
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vector
pBT-M-M154A

traM mutation M154A in pBT

This study

vector
pBT-M-M154G

traM mutation M154G in pBT

This study

vector
pBT-M-M154R

traM mutation M154R in pBT

This study

vector
pBT-M-M154C

traM mutation M154C in pBT

This study

vector
pTRG-M

Full-length traM cloned in target

This study

vector, pTRG
pTRG-BctA

Full-length bctA cloned in target

This study

vector, pTRG
pTRG-BmpH

Full-length bmpH cloned in target

This study

vector, pTRG
pTRG-L123S

traM mutation L123S in pTRG

This study

vector
pTRG-M154C

traM mutation M154C in pTRG

This study

vector
pBT-BctAtrunc

Truncated bctA, lacking the Nterminal signaling sequence (32

This study
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amino acids), in pBT vector.
pTRG-BctAtrunc

Truncated bctA, lacking the N-

This study

terminal signaling sequence (32
amino acids), in pTRG vector.
pBT-TraG

TraG of E. coli RP4 plasmid in

This study

pTRG vector
pBT-TetQ

B. fragilis LV23 tetQ in pBT vector

This study

pTRG-TetQ

B. fragilis LV23 tetQ in pTRG

This study

vector

Bacterial Media, Growth Conditions and Optical Density Readings

Escherichia coli cells were grown in Luria-Bertani (LB) medium (1% w/v
tryptone (Sigma), 0.5% w/v yeast extract (Sigma), 1% sodium chloride). Bacteroides spp.
were grown in BHIS medium (3.7% brain heart infusion medium supplemented with
0.0005% hemin and 5 g of yeast extract/liter) in a Coy anaerobic chamber (5% CO2, 10%
H2, and 85% N2). Agar (Difco) was added to broth at 1.5% (w/v) for plating. Media were
sterilized by autoclaving for 30 mins at 15 pounds per square inch prior to addition of
antibiotics.
E.

coli

growth

was

measured

using

a

Spectronic

Genesys

10UV

Spectrophotometer (Thermo Scientific Inc., Waltham, MA) by taking absorbance
readings at a wavelength of 600nm. B. fragilis growth was measured at a reading
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wavelength of 660mn. 1 ml of bacterial culture was measured and compared to cell free
medium as the blank in disposable platic cuvettes (VWR, West Chester, PA).

Antibiotics

All antibiotics were supplied by Sigma-Aldrich, Inc. Antibiotic concentrations
used for the selection of strains and plasmids included the following: ampicillin, 200
μg/ml; clindamycin, 12 μg/ml; streptomycin, 50 μg/ml; spectinomycin, 50 μg/ml;
rifampin, 25 μg/ml; kanamycin, 25 μg/ml; gentamicin 25 μg/ml; tetracycline, 13.5 (for E.
coli) or 5 μg/ml (for Bacteroides spp.).
Antibiotic stocks were prepared at 10X concentrations and stored in 1 ml aliquots
at -200C. Ampicillin, spectinomycin, streptomycin or clindamycin powder was dissolved
in Milli-Q ultrapure water (Milipore Co.) by vortexing. Chloramphenicol was dissolved
in 100% ethanol by vortexing. Tetracycline was dissolved in 50% ethanol (v/v) by
vortexing. All antibiotics were filtered sterilized through 0.25 μm syringe filters (Pall
Corporation, East Hill, NY) attached to 5 ml syringes.

Recombinant DNA Techniques.
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Plasmid DNA was prepared by affinity purification (Qiagen, Chatsworth, CA).
Restriction endonucleases and DNA ligase were purchased from New England Biolabs
(Beverly, MA). PCR was performed using a commercially available kit that contained the
Amplitaq-Gold DNA polymerase (Applied Biosystems, Foster City, CA). DNA
sequencing was performed using an ABI377 sequencer at the DNA sequencing facility of
the University of Florida, Gainesville, FL.

B. fragilis Genomic DNA Preparation

B. fragilis genomic DNA was purified from 5 ml overnight cultures by using
DNeasy Blood and Tissue Kit (Qiagen) according to the manufacturer’s instructions with
some modifications. Briefly, 5 ml of overnight culture was harvested and centrifuged at
7, 500 rpm for 10 mins. Cell pellets were then resuspended in 900 μl ATL lysis buffer.
100 μl of proteinase K was added to the lysis and mixed by vortexing. Lysis was then
incubated at 550C for 15 mins with vortexing occasionally during incubation and was
vortexed for 15 secs. 1 ml of AL buffer was added to the sample with vortex, incubated
for 10 mins at 700C. Then, 1 ml of HPLC purified Ethanol (Sigma) was added and
vortexed, and the lysate added to a DNeasy Mini Spin column, centrifuged at 8,000 rpm
for 1 min to discard flow through, and then harvested in new 2 ml collection tubes. 500 μl
of the first wash solution AW1 was then added, and the column centrifuged for 1 min at
8,000 rpm. The column was then placed in another new 2 ml collection tube, 500 μl of
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the second wash solution AW2 added, and centrifuged for 3 mins at 14,000 rpm to dry
the DNeasy membrane. The column was then placed in a clear 1.5 ml microcentrifuge
tube, 200 μl of elution buffer AE added, incubated at room temperature for 1 min, and
centrifuged for 1 min at 8,000 rpm to elute.

B. fragilis RNA Purification, RT-PCR and Quantitative PCR

B. fragilis overnight cultures were sub-cultured in pre-reduced BHIS liquid media
under anaerobic conditions from an overnight (ON) culture with the ratio of 1/50. When
the OD660 = 1.2 (about 1.5 hrs after culture), the culture was stimulated with tetracycline
to a final concentration of 1 μg/ ml. About 4 hrs after tetracycline induction, when
bacteria reached mid-exponential phase, OD660 = 0.6, 0.5 ml of each culture was collected
for RNA purification.
RNA for RT-PCR was purified using Qiagen RNeasy mini kit and protocol. For
RT-PCR of BTF-37 11 ORFs, Biorad RT-PCR kit was used for RT-PCR reactions. The
RNA was tested for DNA contamination by checking RT-PCR products from reactions
with or without reverse transcriptase. The transcript production from each of 11 ORFs
was investigated by RT-PCR with specific primers from 250 ng purified RNA. RT-PCR
from 16S was used as the control and for normalization. RT-PCR from tetQ was used as a
positive control. RT parameters: 250C: 5 min, 420C: 30 min, 850C: 5 min. cDNA was
diluted to 1:5 then diluted DNA was used for PCR reaction. PCR parameters: 950C: 5
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min, 25 cycles of (950C: 15sec, 510C: 30sec, 700C: 30sec), 720C: 7 min. RT-PCR
products were examined on 1% agarose gels. The concentration of DNA was measured
by densitometry in an imaging system FluochemTM 8900, Alpha Innotech, and was
normalized according to the density of 16S rDNA transcripts.
RNA for Q-PCR was purified using Ambion MICROBExpress™ Bacterial
mRNA Enrichment Kit (Applied Biosystem, Carlsbad, CA), following the manufacturer
instructions. However, due to easy contamination of DNA in the B. fragilis RNA
samples, RNA containing columns were digested three times with DNAse before elution
to collect pure RNA. The RNA was tested for DNA contamination by checking on
agarose gel RT-PCR products from reactions with or without reverse transcriptase.
Quantitative PCR reactions were performed using SYBR labeling technique,
using 5 Prime reagent kits (5 Prime, Gaithersburg, MD) and Eppendorf Realplex Q-PCR
(Eppendorf, Hamburg, Germany) machine.
Q-PCR data was analyzed using the ΔΔCt method (77):
E = Efficiency; ref = reference gene; gene = test gene
Relative expression = (E gene) x ΔCt gene (Tc--Tc+)
Adjusted relative expression (REadj) = RE (unkown) x 1/RE (ref).
Reference gene: 16S rDNA for expression of tram in B. fragilis LV23 with or without
conjugation condition induction; tetQ for expression of tram in B. fragilis LV23 strains in
the presence of different antisense constructs.
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Table 5. Primers used for RT-PCR and Q-PCR
Primers

Sequence

ORF1 Fwd

TTG CTT TGC ACC ATG ATT TT

ORF1 Rev

GGG CGT GAA GAA CTT GTA GC

ORF2 Fwd

GCC AAT GAA GCA AAA ATT CC

ORF2 Rev

TGC ATA TTG CGA GAA GGT G

ORF4 Fwd

TTG TCG GGA CAG ATG TAA ACC

ORF4 Rev

CCC CGG AGC TAA TGT TTG TA

ORF5 Fwd

TAT CCC GTT ATT GCG TCC AT

ORF5 Rev

ATA GCC TTG CTT CGT GCT GT

ORF6 Fwd

GCG AGT TCT GCA ACA GTA ACA

ORF6 Rev

TTT TCA GTG CGT GGA ATT TG

ORF7 Fwd

CGA AAA ATC CCG CAG AAG TA

ORF7 Rev

ATG CGT ACT CGG CTA CCA TC

ORF8 Fwd

GCA GGT GAA AAC CCA GAA GA

ORF8 Rev

CCA GTA GGA ATA TCG CCA ACA

ORF9 Fwd

ATT TCA GGA GGT TGG CAA TG

ORF9 Rev

GCA CCT ATG CCG AAT GTT TT

ORF10 Fwd

TGC CGC AAT AAT GAA CTT TG

ORF10 Rev

AAG TGC GTT CCT CCA ATG AT

ORF11 Fwd

AGA GCA GCA GCA GTA GGA AA
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ORF11 Rev

TTT TAG CAC GTC CAG CTT CA

16S 1F

GGG GTT CTG AGA GGA AGG TC

16S 1R

CTT CGC AAT CGG AGT TCT TC

TetQ-1369F

ATC GTC GTC ATG GTT GCA TA

TetQ-1527R

GGT GTG AAT TTG GAG CGT TT

Measuring DNA and RNA Concentration

DNA and RNA concentrations were measured using a NanoDrop 1000
Spectrophotometer (Thermo Scientific).

Preparation of Competent E. coli cells and Transformations

Preparation and storage of competent E. coli cells to be used for transformation
was adapted as described previously (128). A fresh, single colony of E. coli cells was
grown in 5 ml of LB media overnight. 500 μl of the overnight culture was diluted 1: 100
in 50 ml of competent cell growth media (LB medium supplemented with 10 mM
magnesium sulfate (Mg2SO4) and 0.2% (w/v) glucose). Cells were grown to mid-log
phase to an optical density reading of about 0.6 at wavelength of 600nm. Cells were then
incubated on ice for 10 mins, and centrifuged at 3000 rpm for 10 mins at 40C in the
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Beckman Allegra X-15R bench top centrifuge to pellet the cells. Cell pellets were then
resuspended in 500 μl of cold competent cell growth media. 2.5 ml of cold competent cell
storage (LB medium supplemented with 36% glycerol, 12% (w/v) polyethylene glycol
(PEG) and 12 mM Mg2SO4) was added to the cells. 200 μl aliquots of cells were
transferred into pre-chilled microcentrifuge tubes and stored at -800C.
Ligation reactions of a sub-cloning procedure or plasmids or a mixture of
plasmids for a bacterial two hybrid experiment were introduced into E. coli competent
cells by transformation. A desired amount of DNA (10 ng of plasmid, or 20 μl of a
ligation reaction, or a mixture of 50 μg DNA of both the bait and the target plasmids in a
bacteria two hybrid experiment) were pipetted into a polypropylene tube and chilled on
ice. 100 μl of competent cells were thawed on ice and transferred to the tube with DNA.
The cells were incubated with the DNA on ice for 30 mins, heat shocked at 420C for 30
secs and then chilled on ice for 2 mins. 900 μl of LB medium was added to the cells and
they were grown at 370C shaking at 250 rpm for 1 h. 100 μl of the transformation culture
was plated onto a selective medium plate. The remaining 900 μl of cells were centrifuged
at 3500 rpm for 5 mins in the Beckman centrifuge. The pellet was gently resuspended in
100 ml of LB medium and plated onto selective medium plate. Plates were incubated at
370C overnight to promote colony growth.
Special growth conditions were applied for transformations for bacterial two
hybrid assays. This is described in the bacterial two hybrid assay section.
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Non-denaturing Protein Purifications

To prepare for Far-Western experiments, non-denatured BctA and BmpH proteins
were purified from pA8-Xa and p17Xa expression vectors, respectively, in XL1-Blue
cells. Briefly, 25 ml of LB medium was inoculated with 500 μl of overnight culture cells
of XL1-Blue pA8-Xa or XL1-Blue p17Xa, and grown at 370C with shaking at 250 rpm.
For induction of BctA from pA8Xa expression vector in XL1-Blue cells, 1 mM final
concentration of IPTG was added to the culture at mid-logarithmic phase (OD600nm=0.5).
For induction of BmpH from pDEST42BmpH vector, a 0.2% (w/v) final concentration of
L-arabinose was added to the culture at mid-logarithmic phase. After induction, cell
cultures were incubated at 300C, overnight with shaking. After incubation, cells were
harvested by centrifugation at 3500 rpm for 30 min by using a Beckman Coulter Allegra
X-15R bench top centrifuge. Cell pellets were then frozen overnight at -200C. After being
thawed, cell pellets were resuspended in 15 ml native lysis buffer (50 mM NaH2PO4,
300 mM NaCl, 1.5% Tween-20, pH 7.5), added 600 μl of proteinase inhibitor cocktail
(Roche, Indianapolis, IN). The cell suspension was gently rocked at room temperature for
2 hrs and then sonicated on ice at 55% for 6 x 30 secs pulse with 30 secs rest in between).
Lysates were cleared by centrifugation at 2850 g, 40C for 30 mins and then applied to
TALON cobalt affinity column (Clontech, Mountain View, CA) pre-equilibrated with 2 x
1 ml lysis buffer and 1 x 0.5 ml lysis buffer plus 0.5 ml wash buffer (50 mM NaH2PO4,
300 mM NaCl, and 15 mM imidazole, pH 7.5). Columns were then washed 3 x 1 ml of
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wash buffer. Immobilized His-tagged proteins were eluted in 3 x 550 μl fractions (50 mM
NaH2PO4, 300 mM NaCl, and 200 mM imidazole, pH 7.5)
Protein Preparation from B. fragilis Cultures

To collect proteins from B. fragilis cultures, overnight cultures were subcultured
in 1: 50 dilution to 45ml of pre-reduced BHIS medium, grown anaerobically at 370C until
mid-logarithm phase (OD660nm=0.5). Cells were then harvested by centrifugation at 3500
rpm, 40C for 30 mins in a Beckman Allegra X-15R centrifuge. Pellets were then
resuspended in 3.5 ml PBS, protease inhibitor added (Roche, Indianapolis, IN), sonicated
for 4x 15 secs with 15 secs rest in between at 45% power, then centrifuged at 11,000 rpm,
40C for 1 hr using Beckman Coulter TLA 100 Ultracentrifuge with a TLA100.3 rotor.
Supernates containing total proteins were collected and stored at -200C overnight. The
next day, supernates were thawed on ice, centrifuged at 70,000 rpm, 40C, for 2 hrs using
Beckman Coulter TLA 100 Ultracentrifuge with a TLA100.3 rotor, and cytoplasmic
proteins collected from supernatant liquids. Pellets were washed with 3 ml PBS and
centrifuge at 70,000 rpm, 40C, for 2 hrs, after which, those supernatant fluids were
discarded. Pellets containing membrane proteins were resuspended in 600 μl PBS,
sonicated 4x 15 secs with 15 second rest in between, at 45%.

Protein Quantification
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In most cases, the concentrations of total proteins was measured using the
Bicinchoninic Acid (BCA)TM Protein Assay Kit (Pierce), according to the manufacturer’s
instructions. A series of dilutions of known concentration of bovine serum albumin
(BSA) was prepared and assayed together with the unknown protein and then the protein
concentration of the each unknown sample was determined in μg/ml based on the
standard curve.
Purified His-BctA, His-BmpH and TraM-His in elution buffer containing 200
mM imidazole were quantified by Coomassie Plus the Better Bradford Kit (Pierce,
Rockford, IL).

Agarose Gel Electrophoresis

The DNA or PCR products were separated by agarose gel electrophoresis with an
agarose concentration of about 1%. The agarose (Sigma-Aldrich) gel was prepared in 1X
TAE buffer (40 mM Tris-acatate, 1 mM EDTA). After the gel was run for a required
time, the DNA was visualized by staining the gel with 0.5 μg/ml of ethidium bromide and
images were taken using AlphaImager automated CCD camera, AlphaInnotech- Cell
Biosciences, San Leandro, CA.
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Polyacrylamide Gel Electrophoresis

Proteins samples were boiled in Laemmli sample buffer (BioRad, Hercules, CA)
containing 5% β-mercaptoethanol in a 1:1 ratio for 10 mins. Samples were then loaded
on Tris-CL polyacrylamide gel in 1 x TGS (2.5 mM Tris-Cl, 19.2 mM Clycine, 0.01%
SDS) (BioRad, Hercules, CA). Electrophoresis was carried out at constant 200 volts for
various times depending on the gel percentage.
Gels were washed for 10 secs in dIH2O and then stained with GelCode Blue Stain
reagent (Thermo Scientific Inc., Waltham, MA) for 60 mins, and destained with dIH2O.

Immunoblot Experiments

Proteins were visualized by western blotting as described previously (199).
Electrophoresis was performed as stated above and gel contents transferred overnight
onto 0.45 μM nitrocellulose membrane at 50 volts in 1 x TG buffer (2.5 mM Tris-Cl,
19.2% Glycine) at 40C with stirring in a Trans-Blot cell (BioRad, Hercules, CA). For
primary antibodies lacking the horse-radish peroxidase label, blots were developed using
a Roche Western Blotting Kit (Roche, Indianapolis, IN). In short, blots were blocked
with shaking for at least 80 mins at room temperature or overnight at 40C, using 1%
blocker in 1X TBS and then incubated for 60 mins with primary antibodies in 0.5%
blocker in TBS, at room temperature. Anti-λcI antibodies and anti-TraM antibodies were
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used at the dilution of 1: 1,000 and 1: 200, respectively. Blots were then washed 3 x 10
mins with TBST (50 mM Tris-Cl, 150 mM NaCl, pH 7.5 and 0.1% Tween 20). Then,
blots were incubated for 30 mins with secondary antibodies, anti rabit and anti mouse
IgG antibodies, washed 4 x 15 mins with TBST. Blots were developed for 1 min using a
mixture of 1 part solution A and 100-1000 part solution B, and exposed to CL-XPosure
film (Pierce, Rockfort, IL).
When using horse-radish peroxidase-labeled (HRP) antibodies like RGS-His and
6x His antibodies (Qiagen, Chatsworth, CA and Clontech, Mountain View, CA), the
western blots were blocked in 1% Casein in TBS (Pierce, Rockford, IL) with 0.1%
Tween- 20, washed with TBST. RGS-His and 6x His antibodies were incubated at
dilution of 1: 25,000 and 1: 10,000, respectively, for 60 mins. No secondary antibody was
required. Blots were developed for 5 mins using North2South Cheminluminescent
substrate for HRP (Pierce, Rockfort, IL), exposed to CL-XPosure film (Pierce, Rockfort,
IL).

Far-Western Blotting Experiments

Far-Western experiments for cell lysates overlayed with purified, non-denatured
BctA or BmpH was performed using a previously published protocol (174). Briefly, the
crude extracts containing λcI-TraM were electrophoresed using SDS-PAGE, and
transferred to a nitrocellulose membrane. The membrane was blocked of free binding
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sites by incubation with blocking solution 1% Casein TBS for 2 hrs. Then, the membrane
was incubated with 10 μg purified His-BctA or 30- 50 μg His-BmpH proteins in 15 ml
1% Casein TBS for 30 mins at room temperature. This incubation allowed BctA or
BmpH to bind to its potential partners. After washing with TBS T/T (TBS with 0.2%
Triton X-100, 0.05% Tween 20), the membrane was incubated with antibodies for His tag
of BctA or BmpH western blot procedure was performed. A negative control Far-western
blot was incubated with anti-His antibodies but not with purified proteins.
Anti-TraM Antiserum Generation

To generate TraM antibodies, TraM was subcloned into the pDEST42 expression
vector, so that TraM was tagged with V5 and 6xhistidine at its C terminal. Full-length
TraM was subcloned into pENTR vector by using NdeI (forward direction) and SacI
(reverse direction) restriction enzymes. pENTR-M and pET-DEST42 were recombined,
according to the manufacture’s instruction to obtain expression clone p42M. p42M was
checked by enzyme digestion and sequencing. The expression vector p42M was
transformed into E. coli BL21AI cells.
TraM-6His was purified from E. coli BL21AI cells by using denatured lysis,
affinity purification and electro elution methods. Briefly, 25 ml of LB medium was
inoculated with 500 μl of overnight culture cells of BL21-AI p42M, grown at 370C with
shaking at 250 rpm. 1 mM final concentration of IPTG were added to the culture at midlogarithm phase (OD600nm=0.5). After induction, cell cultures were grown for 2.5 hrs
further. Cells were harvested by centrifugation at 3500 rpm for 30 min by using a
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Beckman Coulter Allegra X-15R centrifuge. Cell pellets were then freezed overnight at 200C. After being thawed, cell pellets were resuspended in 15 ml denatured lysis buffer
(50 mM NaH2PO4, 300 mM NaCl, 8 M urea, pH 7.5), and 600 μl of proteinase inhibitor
cocktail (Roche, Indianapolis, IN). The cell suspension was gently rocked at room
temperature for 2 hrs and then sonicated on ice at 55% for 6 x 30 secs pulse with 30 secs
rest in between. Lysates were cleared by centrifugation at 2850 g, 40C for 30 mins and
then applied to TALON cobalt affinity column (Clontech, Mountain View, CA) preequilibrated with 2 x 1ml lysis buffer and 1 x 0.5 ml lysis buffer plus 0.5 ml wash buffer
(50 mM NaH2PO4, 300 mM NaCl, and 15 mM imidazole, pH 7.5). Column was then
washed 3 x 1 ml of wash buffer. Immobilized His-tagged proteins were eluted in 3 x 550
μl fractions (50 mM NaH2PO4, 300 mM NaCl, and 200 mM imidazole, pH 7.5). All
affinity purified TraM was applied in a prep PAGE gel and electrophoresed. 500 μl of
proteins was loaded in the large lane, while 50 μl was loaded in a small lane to serve as a
reference. The reference lane was cut out of the gel and was stained with GelCode Blue
Stain Reagent (Pierce, Rockfort, IL). Meanwhile, the prep lane was submerged in a small
amount of TGS buffer and kept at 40C. After staining, the reference gel was used as a
reference to align the size of TraM in the prep gel. Polyacrylamide gel at TraM expected
size was cut out of the prep gel, cut into small pieces and subjected for electro elution.
Protein elution was performed using a Bio-Rad electro eluter 422 (BioRad,
Hercules, CA), according to manufacturer’s instruction. Briefly, membrane caps were
soaked in TGS, protein elution buffer, for at least 1 hr at 600C and was placed into the
bottom of silicone adaptor, filled with TGS, then slided onto the bottom of the elution
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glass tube with frit. Each tube was filled with TGS and placed gel slices. Protein was
eluted at 8-10 mA/ glass tube constant current for 6-8 hrs. After the elution was
completed, proteins were collected from the membrane caps. Proteins were also checked
by western blot to confirm purification.
About 5 mg of purified TraM in TGS were submitted to Alpha Diagnostic
International (San Antonio, TX) for custom antibodies production. Antiseria were
generated by injected antigen (TraM) to two rabbits five times with 14 days intervals.
Immune bleeds (antisera) were collected at week 7 and week 9. Final antiserum was
collected at the end of the procedure (63 days). Antisera were tested by western blot.
Final bleeds from both rabits were mixed and subjected for affinity purification. 5 mg of
purified TraM in TGS was dialysed to PBS plus 0.01% SDS, and was applied for
preparation of affinity column. Antibodies collected from affinity purification were tested
using ELISA and western blot for purification.
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Figure 9. pET-DEST42 expression vector map (Invitrogen)
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Bacterial Two Hybrid Studies

Bacterial

two-hybrid

screens

were

performed

using

the

Stratagene

BacterioMatchII two hybrid system (Agilent Technologies, La Jolla, CA), according to
the manufacture’s instruction with some modifications. Briefly, bait genes (bctA, bmpH,
traM or traM mutants) were constructed in fusion with the full-length bacteriophage λ
repressor protein (λcI) in the bait vector, pBT. Expressions of bait proteins were tested on
western blots using anti-λcI or anti-TraM antibodies. Target genes (bctA, bmpH, traM
(orf7), traM mutants, orf5, orf6, etc.) were fused to the N-terminal domain of the αsubunit of RNA polymerase in the target vector, pTRG. The bait is pulled to the
λ operator sequence upstream of the reporter through the DNA binding domain of λcI.
When the bait and target interact, they recruit and stabilize the binding of RNA
polymerase to at the lacZ promoter, activating the transcription of the HIS3 and aadA
(Strr) genes. HIS3 encodes a component of the histidine biosynthetic pathway that
complements a hisB mutation in the reporter strain. The HIS3 gene product is produced
from the reporter gene cassette at low levels in the absence of transcription activation,
allowing the reporter strain to grow on minimal medium lacking histidine. The compound
3-amino-1,2,4-triazole (3-AT) acts as a competitive inhibitor of the HIS3 gene product. In
the presence of 5mM 3-AT, the reporter strain is unable to grow on media lacking
histidine. When the reporter strain is co-transformed with hybrid bait and target proteins
that interact, the RNA polymerase is recruited to the promoter, activates the transcription
of HIS3 and allows the cells to grow on selection media containing 5mM 3-AT.
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50 ng of each of the bait and target plasmids were co-transformed, and grown in
LB rich media for 90 mins. Cells were then washed 3 times by centrifugation at 2000 g
with 1 ml of M9 His-dropout broth (histidine drop out amino acid supplement in M9
media additive broth). M9 His-dropout broth: 1X M9 salt (Clontech, Mountain View,
CA), 0.4% glucose, 0.2 mM andenine HCl, 1X His dropout amino acid supplement
(Clontech, Mountain View, CA), 1 mM MgSO4, 1 mM Thiamine HCl, 10 μM ZnSO4,
100 μM CaCl2, 50 μM IPTG. Then, cells were grown in M9 His- dropout broth for 2.5
hrs before being plated on non-selection plates prepared from M9 His- dropout broth and
0.17% agar, containing antibiotic selection for both plasmids (25 μg/ml chloramphenicol
and 12.5 μg/ml tetracycline). Cells were allowed to grow on non-selection plates at 370C,
overnight. Cells were then replica-plated on selection plates containing 25 μg/ml
chloramphenicol, 12.5 μg/ml tetracycline 5mM 3-AT, 370C, overnight. The next day,
cells were replica-plated on double selection plates containing 25 μg/ml chloramphenicol,
12.5 μg/ml tetracycline, 5 mM 3-AT and 12.5 μg/ml streptomycin. The percentage of
cells grown on double selection plates was calculated by dividing the number of cells on
the double selection plate and the number of cells on the non-selection plate.
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Figure 10: Schematic of the BacterioMatch II two-hybrid system dual reporter
construct (adapted from Agilent Technologies).
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Bacterial Sub-cellular Fractionation Experiments

To determine if TraM is associated with the membrane, a cellular fractionation
was carried out as previously described (77). Briefly, traM was cloned into pDEST42
vectors so that TraM is tagged with 6xHis at its C terminus. E. coli harboring TraM- x6
His-V5 construct was harvested and lysed under non-denaturing conditions using
phosphate-buffered saline (PBS) and sonication. Sonicates were then centrifuged at 1300
X g to separate crude bacterial debris from total lysate. After addition of protease
inhibitor cocktail (Roche, Indianapolis, IN), clear lysates were centrifuged at ultra-high
speed, 265,000 X g for 2.5 hrs to separate total membrane in the pellet and cytoplasmic
proteins in the supernatant (77). The pellets containing membrane proteins were then
further centrifuged at high speed in PBS and were sonicated to solubilize membrane
proteins. Proteins were quantitated and an equal amount of proteins were electrophoresed
on SDS-PAGE gel, then, transferred to nitrocellulose membranes and subjected to
Western blotting using anti-His antibodies coupled to horseradish peroxidase RGS-His
antibodies (Qiagen, Chatsworth, CA).
To determine if TraM was associated with the inner membrane, cellular
fractionation experiments to separate the inner and outer membrane fractions of E. coli
BL21AI p42M cells were performed as previously described (52). Saturated bacterial
cultures were diluted 1/50 in 25 ml LB medium. When cell density reached an OD595nm of
0.5 - 0.6, cells were induced with 1 ml of 20 % L-arabinose for 2 h. The culture was
harvested, centrifuged at 3500 rpm in Beckman X-15R centrifuge for 30 min 40C,
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washed with phosphate buffer saline (PBS) and resuspended in 1 ml of 50 mM Tris (pH7)-20 % sucrose with protease inhibitors. Cells were treated with 40 μl of 0.25 M EDTA0.25 mg of lysozyme/ ml (final concentration of 10 mM and 10 μg/ ml, respectively), for
10 min at room temperature. The periplasmic fraction was isolated from the rest of the
cells by centrifugation at 8,000 X g for 10 min. The pellet was resuspended in 1 ml of
sonication buffer (10 mM Tris-HCl pH 7 and proteases inhibitors) and sonicated three
times for 15 secs each time at (Fisher sonicator, 55% power). Unbroken cells were
removed by centrifugation at 16,000 g for 2 min, and the clear lysate supernatant
containing cytoplasmic proteins and inner and outer membranes was removed and
centrifuged for 1 hr at 31,000 X rpm to pellet the membranes (Beckman Coulter TLA 100
Ultracentrifuge with a TLA100.3 rotor). The supernatant containing the cytoplasmic
fraction was removed; the membrane pellet was washed with sonication buffer,
resuspended in 0.1 ml sonication buffer with 0.5% N-lauroylsarcosine, which selectively
solubilizes the inner membrane, and centrifuged at 31,000 X rpm for 1 hr. The
supernatant containing the inner membrane fraction was then removed. The outer
membrane pellet was washed with sonication buffer with 0.5% N-lauroylsarcosine. The
final pellet was suspended in 0.2 ml of sonication buffer with 0.5% N-lauroylsarcosine
and 0.1% sodium dodecyl sulfate (SDS). The proteins in each fraction were quantitated
by BCA method and measured by Nanodrop 1000 (Thermo Scientific). Proteins were
added with SDS sample buffer with β-mercaptoethanol, boiled for 10 min, and equal
amounts of proteins from each fraction was electrophoresed using SDS-PAGE,
transferred to nitrocellulose membranes and subjected to immuno-blotting using anti-His
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antibodies coupled to horseradish peroxidase (Clontech, Mountain View, CA). A control
Western blot was probed with anti-OmpA antiserum that detects a specific outer
membrane protein, OmpA. Another control Western blot was probed with anti-DnaK
antiserum that detects a specific cytoplamic protein, DnaK.

Construction of traM antisense RNAs

To knock-down TraM expression in B. fragilis LV23, an antisense approach was
applied. A shuttle vector was constructed so that it carried a traM asRNA fragment
downstream of cfxA promoter (PcfxA). The pFD288 shuttle vector (167) was used for this
construction, and the desired vector was called pFD288MAS1, 2 or 3. Figure 25 shows
the strategy for construction of this shuttle vector. First, cefoxitin pomoter (PcfxA) was
amplified from the shutter vector pFD351 (136), and then subcloned in pFD288, using
PstI and BamHI restriction sites. Then, three different traM- antisense fragments were
amplified from traM in LV23 genomic DNA, subcloned in pFD288P plasmid in opposite
direction to PcfxA, using PstI and EcoRI restriction sites. AS1 is complementary to a
region of 316 nucleotides, covering a putative Shide Dalgano sequence of traM and the
first 166 nucleotides of traM sequence. AS2 has 179 nucleotides, complementary to a
similar segment like AS1 but shorter, also complementary to the first 166 nucleotide of
traM sequence. AS3 is complementary to 120 nucleotides of traM sequence from
nucleotide 102 to nucleotide 221. AS1, 2 and 3 were subcloned in pFD288P in the
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opposite orientation to that of PcfxA, so that, when the plasmid was transcribed, AS1, 2
and 3 RNA would be transcribed in the opposite direction, resulting in mRNA species
that were antisense to traM mRNA.

Table 6: Primers for construction of traM- antisense RNAa.

No

Primer name

Sequence

1

EcoRI-10074Fb

ATCAGAATTCCCAATGCAAGTTTTCAACGA

2

EcoRI-10211F

ATCAGAATTCTGGGAAATTAACTCCAGAAGACA

3

BamHI-10389Rc

CTCAGGATCCCTGCTGGGGCAGAGTTTATC

4

EcoRI-M102F

ATCAGAATTCTGCCCCAGCAGAAGAAACTA

5

BamHI-M221R

CTCAGGATCCTTGAAAGCTCCTTTGAGTGATTC

6

PstI-Pcfx-F

ATCACTGCAGCCATGTTTATATTATTTATATTTGTT
TGACGAG

7

BamHI-Pcfx-R

CTCAGGATCCAAAATCAGTTCTTTAGCGATTAC

a

: AS1 was amplified using primers EcoRI-10074F and BamHI-10389R (the numbers

appear in these primer names indicate the start nucleotide of the primers in BTF-37
contig). AS2 was amplified using primers EcoRI-10211F and BamHI-10389R. AS3 was
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amplified using primers EcoRI-M102F and BamHI-M221R (the numbers appear in these
primer names indicate the start nucleotide of the primers in TraM). Red nucleotides show
restriction enzyme sequences. b: F: forward primer. c: R: Reverse primer.

pFD288MAS1, 2, and 3 were transformed into the conjugation-competent E. coli
cells HB101-RK231 (the RK231 plasmid provides necessary products for DNA transfer
by conjugation). One control was the transformation of the construct pFD288P that
carries just the promoter PcfxA. Another control was the transformation of pFD351
shuttle vector that carries the whole cfxA gene instead of TraM asRNA fragment. The
presence of the vectors in the cells was also confirmed by PCR.
A mating experiment of HB101-RK231-pFD288MAS and B. fragilis strain LV23
to select for transconjugants TcR (select for LV23) and CcR (select for pFD288MAS) was
carried out.
The requirement of TraM for conjugation was tested by performing quantitative
conjugation assays from the donor Bacteroides LV23-TraM AS to the recipients E. coli
HB101 or B. fragilis TM4000. Transconjugants were selected by ampicillin and
streptomycin resistance. Conjugation frequency was calculated relative to the number of
donors.
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Conjugation Experiments

E. coli to B. fragilis mating
Mating experiments to transfer traM-antisense carrying plasmids from E. coli
HB101 RK231 to B. fragilis LV23 were performed as previously described (67). The E.
coli donor strains were grown overnight aerated in LB media containing selective
antibiotics 25 μg/ ml kanamycin for RK231 and 50 μg/ ml spectinomycin for pFD288P
or pFD288MAS plasmids. The B. fragilis LV23 recipient strain was grown overnight in
BHIS broth (brain heart infusion broth supplemented with hemin) with 5 μg/ ml
tetracycline for LV23 strain selection. 500 μl of the recipient overnight culture was
diluted into 25 ml pre-reduced BHIS (1:50 ratio) and grown to mid-logarithmic phase
(OD660nm = 0.6) in anaerobic chamber. About 1 hr and 30 mins after the subcultures of B.
fragilis recipients, the E. coli donor was subcultured from the overnight culture to LB
media in 1:50 ratio, and was grown to early-logarithm phase (OD600nm = 0.4). The donor
and recipient cultures were mixed in 1:1, 1:5 and 1:10 ratios, in which, the donor was
used at 100 μl. The mixtures were centrifuged in 1.5 ml tubes for 2 mins at 3600 rpm in
Eppendorf 5415R centrifuge. Supernatants were discarded. Pellets were resuspended in
50 μl BHIS and plated onto the centers of plain BHIS plates, which were allowed to dry
out and incubated aerobically overnight at 370C. 100 μl of each culture (donor and
recipient) was plated onto BHIS plates supplemented with clindamycin and gentamycin
and was incubated anaerobically at 370C as negative controls. After overnight incubation,
the mixture cells of donor and recipient were scraped from BHIS plates and plated on
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pre-reduced BHIS plates supplemented with tetracycline for selection for LV23 strain,
clindamycin for selection of the shuttle vectors and gentamycin for clearance of E. coli
cells, and were grown anaerobically at 370C for 24 to 48 hrs. Transconjugants were
collected and transconjugant plasmid DNA was prepared and checked by restriction
enzyme analysis.

B. fragilis to E. coli quantitative mating
Quantitative B. fragilis to E. coli filter mating was performed as previously
described (183). B. fragilis strains containing pFD288MAS shuttle vectors or other
control plasmids were used as donors. E. coli HB101 cells were the recipients.
Stationary-phase cultures of the donors were used to inoculate fresh BHIS medium at a
1:50 dilution under anaerobic conditions. Subcultures were induced with 1 μg of
tetracycline/ml after 1.25 hr, and, were grown further for 3 to 4 hrs (optical density at 660
nm reached 0.6). The recipient E. coli cells were subcultured at a 1:100 dilution, 2 hrs
after subcultures of the B. fragilis donors. Recipients were grown aerobically until optical
density at 600 nm was about 0.55. Then, 2.5 ml of donor were applied to 0.45-μm-poresize Nalgene filters, which were vacuumed to remove medium, then washed with 10 ml
of sterile modified phosphate buffered saline (MPBS) (80 mM Na2HPO4, 2 mM
NaH2PO4, 1.45 mM NaCl, pH 6.9), then, mixed with 2.5 ml of the recipient cells,
vacuumed to remove medium. Nalgene filters containing mixture of cells were
aseptically transferred to BHIS agar plates using a scalpel fitted with a disposable blade,
and incubated anaerobically overnight. Following incubation, filters were placed in 5 ml
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of MPBS and vortexed vigorously for 15 secs to loosen cells and suitable dilutions were
plated on selective BHIS media (streptomycin and spectinomycin for selection of HB101
and plasmid pFD288, respectively) and were allowed to grow aerobically. Conjugation
frequency was calculated by dividing the number of transconjugants obtained by the total
number of viable donor cells. Viable donor cells were measured by plating serial
dilutions of the donor strains onto selective medium.

B. fragilis to B. fragilis quantitative mating
Quantitative B. fragilis to B. fragilis filter mating was performed as previously
described (183). B. fragilis strains containing pFD288MAS shuttle vectors or other
control plasmids were used as donors. B. fragilis TM4000 was the recipients. Stationaryphase cultures of the donors and recipient were used to inoculate fresh BHIS medium at a
1:50 dilution under anaerobic conditions. Subcultures of the donors were induced with 1
μg of tetracycline/ml after 1.25 hr, and were grown further for 3 to 4 hrs (optical density
at 660 nm reached 0.6). Then, mating experiments on Nalgene filters were carried as
described in mating experiments from B. fragilis to E. coli. Nalgene filters containing
mixture of cells were aseptically transferred to BHIS agar plates and incubated
anaerobically overnight. Following incubation, filters were placed in 5 ml of MPBS and
vortexed vigorously for 15 secs to loosen cells and suitable dilutions were plated on
selective BHIS media (clindamycin for selection of the shuttle vectors and rifampicin for
selection of the recipients). Conjugation frequency was calculated by dividing the number
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of transconjugants obtained by the total number of viable donor cells. Viable donor cells
were measured by plating serial dilutions of the donor strains onto selective medium.

Site Directed Mutagenesis

Site directed mutations in traM were generated using Stratagene’s QuikChange
Site-Directed Mutagenesis Kit, according to the manufacturer’s instruction. The
oligonucleotide primers containing the designed mutation were designed complementary
to opposite strands of the vector encoded TraM. Extension of the primers created a
mutated plasmid containing staggered nicks. After PCR, the product was treated with
DpnI enzyme. The DpnI endonuclease is specific for methylated and hemimethylated
DNA and is used to digest parental DNA plasmid and select for mutation-containing
newly synthesized DNA. The nicked vector DNA containing the desired mutations was
then transformed into XL-1 Blue supercompetent cells. The cells repair the nick in the
mutated plasmid. The mutated plasmids were sequenced to confirm mutations.
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Table 7: Primers for generation of site directed mutagenesis in traM

Primer

Sequence

1

F66A-Fwd

2

F66A-Rev

3

F66R-Fwd

4

F66R-Rev

5

L69G-Fwd

6

L69G-Rev

7

L69R-Fwd

8

L69R-Rev

9

L123G-Fwd

10

L123G-Rev

11

L123R-Fwd

12

L123R-Rev

5'GAGAGATAAAAAGTAAAGCTGAATCACTCAAAGGAG
CTTTCA-3'
5'TGAAAGCTCCTTTGAGTGATTCAGCTTTACTTTTTATC
TCTC-3'
5'GAGAGATAAAAAGTAAACGTGAATCACTCAAAGGAG
CTTTCA-3'
5'TGAAAGCTCCTTTGAGTGATTCACGTTTACTTTTTATC
TCTC-3'
5'GAGATAAAAAGTAAATTTGAATCAGGTAAAGGAGCT
TTCAATAAATCTTCTG-3'
5'CAGAAGATTTATTGAAAGCTCCTTTACCTGATTCAAA
TTTACTTTTTATCTC-3'
5'GAGATAAAAAGTAAATTTGAATCACGCAAAGGAGCT
TTCAATAAATCTTCTG-3'
5'CAGAAGATTTATTGAAAGCTCCTTTGCGTGATTCAAA
TTTACTTTTTATCTC-3'
5'CTAGAATCCGAGAAAAGGAAGGTGAACAACAAATAA
AAGGATTTCCTAC-3'
5'GTAGGAAATCCTTTTATTTGTTGTTCACCTTCCTTTTC
TCGGATTCTAG-3'
5'CTAGAATCCGAGAAAAGGAAAGGGAACAACAAATA
AAAGGATTTCCTAC-3'
5'GTAGGAAATCCTTTTATTTGTTGTTCCCTTTCCTTTTC
TCGGATTCTAG-3'
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13

L123S-Fwd

14

L123S-Rev

15

M154A-Fwd

16

M154A-Rev

17

M154G-Fwd

18

M154G-Rev

19

M154R-Fwd

20

M154R-Rev

5'AATCAAGCTTCTAGAATCCGAGAAAAGGAATCGGAA
CAACAAATAAAA-3'
5'TTTTATTTGTTGTTCCGATTCCTTTTCTCGGATTCTAG
AAGCTTGATT-3'
5'CAAGATGCAAGAAGAAGCTGAGCTTTTTAAAATGCA
AATGG-3'
5'CCATTTGCATTTTAAAAAGCTCAGCTTCTTCTTGCATC
TTG-3'
5'CAAGATGCAAGAAGAAGGTGAGCTTTTTAAAATGCA
AATG-3'
5'CATTTGCATTTTAAAAAGCTCACCTTCTTCTTGCATCT
TG-3'
5'CAAGATGCAAGAAGAAAGGGAGCTTTTTAAAATGCA
AATG-3'
5'CATTTGCATTTTAAAAAGCTCCCTTTCTTCTTGCATCT
TG-3'

CHAPTER IV
EXPERIMENTAL RESULTS

BctA is Essential for Conjugation from B. fragilis LV23

Previously, our laboratory reported the capture of BTF-37, a 37kb conjugative
transposon, from a clinical B. fragilis isolate, LV23 (181). BTF-37 alone is capable of
facilitating transfer of DNA not only in B. fragilis but also in E. coli (181). Due to many
repeat A-T rich regions which hinders the sequencing process, only 16kb of BTF-37 was
sequenced. This 16kb region carries 11 ORFs. By sequence homology analysis with other
Bacteroides known transfer factors, and by RT-PCT studies, these 11 genes likely
correspond to the transfer region of BTF-37 (77). Of these 11 ORFs, bctA is an ORF
highly conserved between different Bacteroides transposons.
BctA encodes a putative coupling protein of BTF-37 CTn (77). It is identical to
the putative coupling protein BctA of B. fragilis conjugative plasmid pBF4, 98%
identical to that of the B. fragilis NCTC9343, 74% to the B. fragilis YCH46 strain from
Japan, and 48% to a BctA homolog from the B. fragilis CTnDOT conjugative transposon
(77). Computer analysis also reveals that BctA has two Walker-box-sequences, ATPhydrolysis motifs, as characteristic of a coupling protein. Previous studies from our
81

82
laboratory also shown that BctA has a signal sequence required for membrane
localization and that it is indeed associated with the membrane. Moreover, BctA
expression is upregulated under conjugation conditions and purified BctA migrates as a
tetramer under non-denaturing PAGE (77).
To determine if BctA is required for conjugation in B. fragilis LV23, we
generated a bctA null mutant. The traditional method is to introduce into a B. fragilis
parent strain a suicide vector (pFD516) carrying a disrupted form of bctA gene (the
middle region of bctA gene is disrupted by a cfxA gene). Previous work from our
laboratory has shown it was very difficult to generate such a null mutant in the parental
LV23 strain. Therefore, a bctA null mutant was generated from the parental
TM4000BTF-37 strain. TM4000 is a transfer deficient strain. TM4000BTF-37 is a DNA
transferrable strain carrying BTF-37 CTn generated by introduction of pBTF-37 into
TM4000. The scheme for the selection of the TM4000BTF37bctA transconjugants was
depicted in figure 11A. Figure 11B shows evidence of the presence of the disrupted bctA
gene in the chromosomes of transconjugants, as seen by the PCR products of the
amplifications of the right arm of the disrupted bctA gene, a region of about 1.6kb
covering a cfxA gene insertion and the right flanking region of bctA. This evidence
confirmed that the TM4000BTF37bctA transconjugants are true null mutants. First, this
amplification cannot be from the original suicide vector because this suicide vector
cannot replicate in B. fragilis, thus it should not present in the transconjugatns after
several passages. Second, if the construct can insert into somewhere into the
chromosome, we expect to be able to amplify not just the disrupted form of bctA but also
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its orginal gene. Third, if bctA was not truly deleted due to the non-resolution of the
suicide vector, a large portion of the suicide plasmid is still present in the chromosome,
then a short species of 1.6kb PCR product should have not been detected.
To test for the transfer frequency of TM4000BTF37bctA null mutant, a shuttle
plasmid pGAT400 was introduced into each test strain by conjugation from E. coli
HB101 donor, and then this pGAT400 plasmid was used as a transferrable DNA to be
measured in quantitative conjugation experiments. Quantitative conjugation experiments
were carried out from donors TM4000BTF37bctA-GAT400 to the transfer deficient strain
TM4000. Positive controls were mating experiments from donors LV23GAT400 and
TM4000BTF37-GAT400 to TM4000. A negative control was the mating from TM4000GAT400 to TM4000. Figure 11C shows that BctA is indeed required for the conjugation
of BTF-37 CTn in B. fragilis. bctA KO strains were totally defective in DNA transfer
activity.
A complementation assay was carried out to test if the re-introduction of BctA
into BctA KO strain could recover DNA transfer activity. A shuttle plasmid (pFD288BctA) carrying bctA was introduced into TM4000BTF37BctAGAT400. However, the
complementation assay did not work, most likely because BctA was not successfully
expressed in pFD288 shuttle vector. This may due to two reasons. First, the construction
of bctA into pFD288 did not include any promoter region for successful expression of
BctA. A reconstruction of pFD288-BctA including an upstream region of bctA, which
most likely carries an original bctA promoter region, may solve this issue. Another
solution is to use a promoter known to work well in B. fragilis to drive the expression of
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bctA, such as cefoxitin promoter PcfxA. Second, the fact that pFD288 is a low copy
shuttle vector obviously affects the level of expression of BctA. The use of a better
shuttle vector system may help solving this problem. The lack of an anti-BctA antibody
also hindered the verification of BctA expression.
However, the lack of a supporting complementation assay data does not preclude
the likelihood that BctA is truly essential for conjugation mediated by BTF-37 in B.
fragilis.
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Figure 11. BctA is required for conjugation mediated by CTn BTF-37 in B. fragilis.
A) Strategy to generate a bctA mull mutant in B. fragilis TM4000BTF-37. B) Evidence
for the presence of bctA disrupted construct in transconjugant chromosomes. C) bctA null
mutants (TM4000BTF37bctA #5 and #8) abolishes DNA transfer capacity of BTF-37 as
measured by transfer frequency of GAT400 plasmid.
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BTF37 Genes are Involved In Conjugation Process in B. fragilis LV23

Although the formation of the conjugal apparatus is well studied in other
conjugative systems such as A. tumefaciens Ti plasmid and E. coli F and RP4 plasmids,
little is known about its structure and function in Bacteroides spp. (181). BTF-37, a
conjugative transposon isolated from the B. fragilis clinical isolate LV23, harbors genes
encoding conjugal apparatus proteins and confers mobility on non-mobile plasmids
(181). To identify important conjugal apparatus components, we investigated the
expression of BTF-37 genes under conjugation conditions, i.e. when Bacteroides cells are
stimulated with a low level of tetracycline (≤ 1 µg/mL). Under these conditions, the
frequency of conjugal transfer has been shown to be elevated 1,000-10,000 fold (160,
173), and is likely directly related to the increased expression of proteins that assemble
into the conjugal apparatus. Thus, we hypothesized that if transcript production from a
BTF-37 gene was up-regulated under tetracycline induction conditions, that gene product
may be involved in the DNA transfer process.
Using semi-quantitative RT-PCR, we found that expressions of all 11 ORFs in the
known 16 kb sequence of BTF-37 were up-regulated when B. fragilis cells were exposed
to tetracycline. After normalization with 16S rDNA expression, the transcripts of the 11
ORFs were up-regulated 1.2 to 2.1-fold. traM- orf7 transcription was elevated 1.5 fold,
similar to that previously observed for bctA (77).
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We have previously reported that bctA expression is elevated to a maximum of
2.5-3 fold using real time RT-PCR and spot densitometry, respectively (77). These low
(but consistently reproducible) levels of transcript up-regulation are likely due to the gene
products being membrane-associated or integral membrane proteins; thus they cannot be
highly over-expressed without deleterious effects to the cells. Further, actual DNA
transfer events from donors to recipient bacteria occur very quickly (likely in secs), and
only one conjugal apparatus is finally formed to connect the donor with the recipient
[40](181). Therefore, these small increases in gene expression are likely sufficient for the
production of a functional conjugal apparatus. Other laboratories have also reported
similarly low increases in conjugal apparatus gene expression that correlate with
increased DNA transfer (C. Jeffrey Smith, personal communication). We therefore
conclude from these results that this up-regulation of conjugal apparatus gene expression
from 1.2-2.1 fold indicated that all 11ORFs of BTF-37 are involved in the conjugation
process.

88

Figure 12. BTF37 conjugative transposon
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Figure 13: mRNA expression of 11 genes in the 16 kb sequenced region of BTF37 in
conditions with and without tetracycline induction. A) a representative 1% agarose gel
profile. +: Tc induction; -: no Tc induction; B) Ratio of gene expression in Tc induction
condition vs no Tc, normalized to the expression of 16S transcripts.
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Identification of BctA and TraM Interaction Partners

The function of a coupling protein is to couple the relaxosome complex to be
transferred though the conjugal apparatus to the recipient. The coupling protein localizes
at the base of the conjugal apparatus and interacts with both the relaxosome complex and
the conjugal apparatus (29, 59, 61). In B. fragilis, such interaction partners of the putative
coupling protein BctA have not been identified. In E. coli and A. tumefaciens,
interactions of many mobilization proteins and conjugal apparatus components with the
coupling protein were initially identified by two-hybrid system and then confirmed by
biochemical experiments (5, 57, 69, 105, 174). Thus, to identify BTF-37 conjugal
apparatus proteins interacting with the coupling protein, similar approaches were
employed.
First, Bacteriomatch II two-hybrid system (Stratagene-Agilent Technologies,
(43)) was employed to screen for gene products that interact with the putative coupling
protein BctA. Briefly, individual BTF37 ORFs were cloned into the “prey” vector,
pTRG; bctA was cloned into the “bait” vector, pBT. The reporter cells (XL-1 Blue MFR
KanR) were co-transformed with 50 ng each of bait and prey plasmids, phenotypically
expressed transformant genes in His- minimal media, plated on nonselective plates for
24hrs then replica plated on selective media containing 5mM 3AT, and then on dual
selective plates containing 5mM 3AT and streptomycin. All plates had 25mM
chloramphenicol and 12.5μM tetracycline throughout to select for bait and prey plasmids.
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The strength of interaction was calculated as the percentage of the co-transformed
colonies that grown on the double selection plates. This was calculated by dividing the
number of colonies on double selection plate for the number of colonies that grown on
the non-selection plate. BctA was also exmanined for its stable protein production
(Figure 14A). Our results of the bacterial two hybrid experiment in Figure 14B indicate
that BctA interacts with ORF7 and ORF8 and that the interaction with ORF7 is stronger
than with ORF8. From sequence homology analysis, ORF7 and ORF8 are homologous to
TraM and TraN in other Bacteroides spp. CTn’s, respectively.
Of particular interest, BTF-37 ORF7 (TraM) is a 393 amino acid protein, and has
92% sequence identity to TraM in B. fragilis NCTC9343, 61% to TraM of B. fragilis
YCH46, 32% to TraM of B. thetaiotaomicron CTnDOT and 28% to B. vulgatus CTn341.
It

is

predicted

to

be

a

membrane

(http://www.cbs.dtu.dk/services/TMHMM/)

protein

by

the

and

TMHMMM
DAS

(http://www.sbc.su.se/~miklos/DAS/maindas.html) membrane predicted programs (37).
Moreover, deletion studies from CTn341 shown that TraM is required for conjugation
(7), indicating that TraM is an important component of the conjugal apparatus in
Bacteroides spp. Thus, we decided to focus our study on ORF7 (TraM).
Another two-hybrid screen was performed, in which, traM was used as the bait
and other genes were constructed in the target vector. Our results further confirmed that
TraM interacts with BctA (both BctA full-length and N-terminal truncation).
Interestingly, TraM interacts with BmpH and ORF8 (TraN). A positive control for BmpH
interaction was the interaction between E. coli TraG and BmpH. Work from our
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laboratory has previously shown that TraG of E. coli RP4 plasmid system interacts with
the B. fragilis relaxase BmpH of the Tn5520 mobilizable plasmid.
This was the first time a two-hybrid approach was used to study the interactions
of Bacteroides spp. conjugal apparatus component proteins with a putative coupling
protein as well as a relaxase. These data indicate that TraM interacts with BctA, ORF8
(TraN) and BmpH, of which, the interaction of TraM with BctA is strongest. Thus, TraM
is likely a conjugal apparatus component protein at the base of the CA and interacts with
the putative coupling protein BctA. This in vivo interaction between TraM and BctA is
the first demonstration of an interaction of the CP with a CA component protein in
Bacteroides spp. This is also the first demonstration of a CA component protein in
Bacteroides spp. interacting with a relaxase. In E. coli F plasmid conjugative system, the
relaxase forms a complex with some other partners such as IHF, TraM and TraY but they
are mostly cytoplasmic proteins and not involved in the CA (142). Thus, if this
interaction is true, it is an interesting finding, supporting the idea that the conjugation
molecular mechanism in Bacteroides spp. is distinct from that of E. coli.
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Figure 14: Bacterial two-hybrid analysis of interactions between BctA and other
BTF37 gene products (data from a representative experiment). A. Western blot shows
full-length BctA in fusion with λ-cI in the bait vector. Cells: reporter cells (XL-1 Blue
MFR KanR), pBT: reporter cells expressing the bait vector alone, pBT-BctA: reporter
cells expressing BctA in bait vector. B. Interactions of BctA with other BTF-37 gene
products. Individual BTF37 ORFs were cloned into the “prey” vector; bctA was cloned
into the “bait” vector. The reporter cells (XL-1 Blue MFR KanR) were co-transformed
with 50 ng each of bait and prey plasmids, phenotypically expressed transformant genes
in His- minimal media, plated on nonselective plates for 24hrs then replica plated on
selective media containing 5mM 3AT, and then on dual selective plates containing 5mM
3AT and streptomycin. All plates had 25mM chloramphenicol and 12.5μM tetracycline
throughout to select for bait and prey plasmids.
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Figure 15: Bacterial two-hybrid analysis of interaction of ORF7 (TraM) with other
BTF-37 gene products (data from a representative experiment). A. Western blot shows
full-length ORF7 (TraM) in fusion with λ-cI (a total MW of about 72kD) expressed in
the bait vector. Cells: reporter cells (XL-1 Blue MFR KanR), pBT: reporter cells
expressing the bait vector alone, pBT-ORF7: reporter cells expressing ORF7 (TraM) in
the bait vector. B. Interactions of ORF7 (TraM) with other BTF-37 gene products. BctA
truncation is a construct that does not have the N terminal cleavage signal of BctA.
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Hypothesis

Of all the putative conjugal apparatus genes encoded by BTF-37, we were
interested in ORF7 (TraM) because our bacterial two-hybrid data showed that TraM
strongly interacted with the putative coupling protein BctA and that it also interacted with
the relaxase BmpH. Computer analysis of our BTF-37 TraM showed that it harbors
characteristics of a required conjugal apparatus protein. First, this 393 amino acid protein
exhibits sequence conservation with other Bacteroides spp. conjugal apparatus proteins,
i.e., 92% sequence identity to TraM in B. fragilis NCTC9343, 61% to TraM of B. fragilis
YCH46, 32% to TraM of B. thetaiotaomicron CTnDOT and of B. vulgatus CTn341.
Second, TraM was predicted to be associated with the membrane, suggesting its function
as a member of the transverse-membrane mating channel. Third, previous study shown
that our TraM homolog in B. vulgatus CTn341 is required for conjugation, indicating that
our BTF-37 TraM may also be important for conjugation in B. fragilis (7). Moreover, our
preliminary data indicated that TraM interacts with both the putative coupling protein
BctA and the relaxase BmpH, suggesting a special role of TraM in DNA transfer process
in B. fragilis.
We, therefore, hypothesized that TraM is an important conjugal apparatus protein
of the conjugative transposon BTF-37. If TraM is an important member of the
Bacteroides spp. conjugal apparatus, then its function must be elucidated in more detail.
In the studies described below, we thus demonstrated that 1) TraM expression is indeed
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upregulated under conjugation conditions; 2) TraM associated with the inner-membrane
and 3) TraM is required for DNA transfer process in B. fragilis. Moreover, we also
investigated the interaction of TraM with its important putative partners, the putative
coupling protein BctA and the relaxase BmpH.

Figure 16. Homology of some of Bacteroides conjugative transposons.
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Figure 17. Summary of conjugal apparatus mutation studies in CTn341, showing
the requirement of TraM for conjugation. Adapted from Bacic, J. Bacteriol, 2005 (7).

97
traM Expression is Upregulated under Conjugation Conditions

TraM is a member of the putative conjugal apparatus operon of the conjugative
transposon BTF-37. If TraM is truly a conjugal apparatus protein, its expression most
likely is up-regulated under conjugation condition. In fact, our reverse transcriptase PCR
study showed that traM expression, along with other genes of the BTF-37 contig was
upregulated when B. fragilis conjugation condition was induced by tetracycline. Thus, we
began our in-depth study of TraM by more accurately quantitating its gene expression
levels under conjugation conditions. We used SYBR-Green based fluorescence for
detection and quantification of traM expression by fully-quantitative real-time PCR (QPCR). The expression of both the 16S rDNA and tetQ genes was used as controls. QPCR data was analyzed using the ΔΔCt method (77). tetQ was used as a positive control,
since it has been previously observed that tetQ transcription is up-regulated ~10 fold
upon tetracycline exposure (77).
Q-PCR revealed that traM gene expression was up-regulated ~2-fold under
conjugation (induction) conditions; thus further strengthening our hypothesis that TraM is
required for Bacteroides spp. conjugation.
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Figure 18. Q-PCR standard curves of 16s rDNA (A), traM (B) and tetQ (C).

Figure 19. traM gene expression under
conjugation conditions. Adjusted relative
expression values were calculated from
mean ΔCt values of three replicate Q-PCR
reactions.
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TraM Interacts with Both The Coupling Protein BctA and The Relaxase BmpH

As presented above, we identified by bacterial two-hybrid analysis that TraM
strongly interacts with both the coupling protein BctA and the relaxase BmpH. In fact, by
performing more quantitative study, we further confirmed that BctA and BmpH interacts
with TraM in E. coli bacterial two hybrid system. Bacterial two-hybrid experiments were
carried out as described in the experimental methods. The strength of interactions were
calculated as the percentage of the positive colonies showing the interaction of the bait
and the target proteins on the double selection plates with the original number of colonies
grew on the non-selective plates. All experiments were repeated in triplicate. As can be
seen from figure 20, TraM interaction with BctA is stronger than that with BmpH.
Moreover, when TraM was expressed in the bait vector, BctA in the target vector, the
strength of interaction of TraM with BctA is not as strong as that of BctA and TraM
(when BctA was in the bait and TraM in the target vector). This was probably due to the
different level of expression of proteins in the bait and the target. We could evaluate the
level of protein expression in the bait vector by performing a western blot using anti-λcI
antibodies, antibodies against the fusion domain of the bait. However, we cannot evaluate
the level of production of the target due to the lack of necessary antibodies. However,
TraM and BctA either in the bait-target or target-bait relationships still show strong
interactions with each other.
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This was the first time a two-hybrid approach was used to study the interaction
between Bacteroides spp. conjugal apparatus component proteins with a putative
coupling protein and a relaxase. These interactions indicate that TraM is likely a conjugal
apparatus component protein at the base of the conjugal apparatus and interacts with the
putative coupling protein BctA. This in vivo interaction between TraM and BctA is the
first demonstration of an interaction of a coupling protein with a CA component protein
in Bacteroides spp. This is also the first demonstration of a CA component protein in
Bacteroides spp. interacting with a relaxase. It is an interesting finding, supporting the
idea that the conjugation molecular mechanism in Bacteroides spp. is distinguished from
that of E. coli.
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A.

B.

Figure 20: Bacterial two-hybrid analysis of A) Interaction of TraM with BctA, B)
Interaction of TraM with BmpH.
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A more direct approach to support our bacterial two-hybrid protein interaction
studies is one based on co-immunoprecipitation analyses. However, due to problems with
compatibility and selection of available expression vectors, Far-Western experiments
instead of co-immunoprecipitation analysis were performed to investigate the interaction
of TraM with BctA and BmpH in vitro. Briefly, 6His-BctA and 6His-BmpH were
expressed in Xl-1 Blue and BL-21 AI cells, respectively. Then the proteins were purified
using native purification lysis buffer and TALON cobalt affinity column (histidine
affinity column). Native proteins were eluted with elution buffer containing 200 mM
imidazole. The crude extract expressing λcI-TraM from pBT-M vector and control cells
(Xl-1Blue cells and XL1-Blue cells carrying p-BT vector alone) were electrophoresed on
SDS-PAGE gel, then were transferred to a nitrocellulose membrane. After blocking, the
membrane was incubated with purified His-BctA or His-BmpH proteins, then with antiRGS His antibodies, antibodies specifc for histidine tag of BctA or BmpH. After that,
western blot was performed as normal. A negative control Far-western blot was
incubated with anti-His antibodies but not with purified proteins to show non-specific
binding of antibodies. Figure 21 showed the presence of His-BctA at the right MW of λcI TraM (~70kD) when purified His-BctA overlayed on membrane harbouring TraM.
This further confirmed that BctA interacted with TraM.
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Figure 21: Interaction of λcI-TraM with BctA. 25 μl of control cell lysates (1: XL-1
Blue cells, 2: XL-1 Blue cells carrying control vector pBT) and of Xl-1 Blue cells
expressing λcI-TraM were electrophoresed and processed for: blot A: western detection
of TraM, blot B: Far western analysis overlaid with native 6His-BctA, blot C: antibody
Far western control blot. Arrow indicates full-length λcI-TraM at 70 kD.
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Moreover, a far western experiment was also carried out to confirm that BmpH
interacted with TraM. Because we encountered difficulty in detecting interaction of
BmpH and TraM in a far western experiment, we tried to obtain a better extraction of
TraM by utilizing different lysis methods. In figure 22, lane 3 and 4 are cell lysates
expressing TraM but with two different lysis methods, 3) using Sarkorsyl detergent and
4) using 1.5% Tween. Overlaid BmpH showed a stronger band interacting with TraM in
lane 4 than lane 3, most likely due to the different lysis conditions. Although this result
was observed only one time, our result still shows that BmpH interacts with TraM in
biochemical assay, supporting the result in the bacterial two hybrid assay. This was
further comfirmed by our far western experiments for interaction of BmpH with TraM
mutant L123S, which will be discussed later. This hard-to-produced data may be because
of the following reasons: 1) purified BmpH is hard to maintain a good native structure for
far-western experiments and 2) the interaction of TraM with BmpH is weaker than that
with BctA, and therefore, is harder to be detected on a far western experiment. BmpH has
high pI of 9.5, has large stretches of positively charge amino acids and is multifunctional.
Thus, as a result, BmpH may non-specifically aggregate in self and non-self associations,
hindering the interaction with TraM on the membrane in a far western experiment.
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Figure 22: Interaction of λcI-TraM with the relaxase BmpH. 25μl of control cell
lysates (1: XL-1 Blue cells, 2: XL-1 Blue cells carrying control vector pBT) and of Xl-1
Blue cells expressing λcI-TraM with two different lysis methods with Sarkosyl detergent
(3) and 0.5 % Tween 20 (4) were electrophoresed and processed for: A: Far western
analysis overlaid with 30 μg native 6-His-BmpH/ 15 ml far western incubation solution,
blot B: antibody Far western control blot.
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TraM is Associated with The Inner Membrane

The conjugal apparatus must be a membrane-traversing channel so that DNA can
pass through from the donor to the recipient bacteria. In fact, studies in E. coli and A.
tumefaciens indicate that most of conjugal apparatus proteins are membrane associated
(63, 100). Computational analysis from TMHMM and DAS transmembrane predicted
servers indicates that TraM is a membrane protein and aa14-30 from the N terminal of
TraM are in the membrane spanning region. Moreover, if our BTF-37 TraM truly directly
interacts with the two key proteins of the conjugation, the coupling protein BctA and the
relaxase BmpH, it is most likely that TraM is associated with the membrane. In addition,
mutational analysis of CTn341 (another Bacteroides sp CTn) show that TraM is required
for Bacteroides conjugal transfer (7). Thus, TraM is most likely a membrane associated
protein required for B. fragilis conjugation; and the interaction between TraM and BmpH
may be required for TraM function in the CA. Moreover, because the potential coupling
protein BctA is expected to be associated with the inner membrane, TraM is also
expected to be in the inner membrane because it interacts with both BctA and the
relaxase BmpH.
First, a simple cell fractionation was applied to determine if TraM is located in the
membrane or cytoplasmic fraction. In this experiment, cells expressing TraM was
separeated into cytoplasmic fraction and membrane fraction by using high speed
centrifugation. We have observed that TraM was strongly associated with the membrane
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fraction and it was not detected in the cytoplasmic fraction. Interestingly, a band above
TraM was observed at about 55kD. This is likely full-length TraM that was completely
processed for signal-sequence cleavage. Although TraM has no computationally
predicted signal sequences, there is still a high possibility that TraM has a signal
sequence as it is a membrane protein. We have observed this for other Bacteroides spp.
CA proteins as well (BctA (77)).
To further examine if TraM is associated with the inner membrane, another
cellular fractionation assay was performed to separate inner and outer membrane
fractions, using high speed centrifugation, sonication and 0.5% N-lauroylsarcosine (as
described in the experimental methods).
Figure 23 shows membrane fractionation of TraM-(6) His. As seen in the blot
probed with OmpA antibodies, the membrane fractionation is still not totally clean, as
indicated by the presence of some outer membrane protein OmpA in both inner
membrane fraction (IM) and outer membrane fraction (OM). However, the majority of
TraM was shown in the IM fraction. This infers that TraM most likely associates with the
inner membrane. This localization of TraM is speculated to support the interaction of
TraM with BctA at the base of the CA and also with the relaxosome via the relaxase
BmpH from the cytosol.
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Figure 23. TraM is associated with membrane fractionation. P: Periplasmic fraction,
C: Cytoplasmic; IM: Inner membrane; OM: Outer membrane. 12μg of total proteins/lane.
A) SDS-PAGE gel stained with Coomassive blue. B) blot probed with 6HIS antiserum
for detection of TraM-6His-V5. C) blot probed with antibodies for DnaK cytoplasmic
protein. D) blot probed with antibodies for OmpA outer membrane protein.
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TraM is Required for Conjugation Within and From B. fragilis LV23
Mutational analysis of CTn341 (another Bacteroides sp CTn) showed that TraM
is required for Bacteroides conjugal transfer (7). Moreover, if BTF-37 TraM truly
directly interacts with the two key proteins of the conjugation, the coupling protein BctA
and the relaxase BmpH, then it is most likely that TraM is essential for Bacteroides
conjugation. Thus, TraM is most likely essential for B. fragilis conjugation and the
interaction between TraM and BmpH may be required for TraM function in the CA.
To determine if TraM is required for B. fragilis conjugation, it is important to
generate a traM null mutant to study if this strain unable to transfer. A traditional method
is to use a suicide vector to deliver a TraM disrupted construct from E. coli to B. fragilis.
However, this method is difficult and time-consuming due to stringent recombination
barriers encountered in B. fragilis. Thus, we decided to suppress the expression of traM
in B. fragilis by using an antisense RNA (asRNA) approach. AsRNAs have been
successfully used to suppress the expression of bacterial proteins in several studies,
especially in the clostridia (118, 125, 138, 143, 177, 178), where very similar difficulties
are encountered in generating KO mutants. A similar approach was employed to generate
a traM mutant that decreases in the expression of TraM.
A shuttle vector carrying an asRNA fragment covering the translation initiation
site of TraM was generated from the shuttle vector pFD288 (167). The transcription of
this asRNA gene should be driven by a strong promoter in B. fragilis. However, the
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promoter present in the shuttle vector pFD288 originated from E. coli and does not work
in B. fragilis. Moreover, in Bacteroides spp., little is known about promoter properties;
and it seems that gene promoters in Bacteroides spp. do not possess similar consensus
sequences like those of E. coli. It has been shown that when the cefoxitin resistance
(cfxA) gene was introduced into B. fragilis along with an upstream region of 146
nucleotides, the gene product was strongly expressed for cefoxitin antibiotic selection
(166). Thus, this 146-nucleotide upstream region of cfxA may contain a strong promoter
region for this gene. Thus, the shuttle vector was constructed so that it would carry a
TraM asRNA fragment downstream of cfxA promoter (PcfxA). And the vectors we
generated were called pFD288MAS1, 2 and 3.

Figure 24. traM-antisense constructs. PcfxA: cefoxitin A promoter. CcR: clindamycin
resistance (for selection in B. fragilis). SpR: spectinomycin resistance (for selection in E.
coli).
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Figure 25. Effect of traM-antisense constructs on conjugation capacity of B. fragilis
LV23 to recipients B. fragilis TM4000 (in blue) or E. coli HB101 (in red). The
frequency of the control B. fragilis LV23-pFD288P was set at 100% for comparison with
test constructs. Other controls pFD288 and pFD351 (pFD288 carrying the whole
cefoxitin gene) did not show significant effect on conjugation.
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Quantitatve conjugation experiments from B. fragilis to B. fragilis and from B.
fragilis to E. coli were carried out to determine if TraM is required for conjugation from
B. fragilis. Experiments were processed using filters as described in the experimental
methods. Briefly, in the quantitative conjugation experiments from B. fragilis to B.
fragilis, B. fragilis strains containing pFD288MAS shuttle vectors or other control
plasmids were used as donors and B. fragilis TM4000 was the recipients. The donor and
the recipients were mixed together on Nalgene filters on working bench. Nalgene filters
containing mixture of cells were aseptically transferred to BHIS agar plates and incubated
anaerobically overnight. Following incubation, filters were placed in MPBS solution and
vortexed vigorously to loosen cells and suitable dilutions were plated on selective BHIS
media (clindamycin for selection of the shuttle vectors in B. fragilis and rifampicin for
selection of the recipients TM4000). Conjugation frequency was calculated by dividing
the number of transconjugants obtained by the total number of viable donor cells. Viable
donor cells were measured by plating serial dilutions of the donor strains onto selective
medium. Similarly, in the quantitative conjugation experiments from B. fragilis to E. coli,
B. fragilis strains containing pFD288MAS shuttle vectors or other control plasmids were
used as donors and E. coli HB101 cells were the recipients. Nalgene filters containing
mixture of donor and recipient cells were also aseptically transferred to BHIS agar plates
and incubated anaerobically overnight. After incubation, cells were loosened from the
filter in MPBS solution and suitable dilutions were plated on selective BHIS media
(streptomycin and spectinomycin for selection of HB101 and plasmid pFD288,
respectively). These selective plates were allowed to grow aerobically. Conjugation
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frequencies were also calculated as described with the quantitative onjugation experiment
from B. fragilis to B. fragilis.
Figure 25 shows the results of the quantitative conjugation experiments. Our data
show that two constructs AS2 and AS3 caused significant impairment to the conjugation
capacity of B. fragilis LV23. AS2-harboring cells exhibited almost 100% reduction in
conjugation frequency. AS3 showed up to 75% and 82% conjugation reduction when
LV23 was mated with B. fragilis TM4000 and E. coli HB101 recipients, respectively.
These results clearly indicated that TraM was required for conjugation. The AS1
construct did not reduce conjugation in B. fragilis TM4000 but did so in E. coli HB101
(up to 100%). This maybe due to several reasons: First, this maybe because AS1 is the
longest RNA fragment (316nt) with the highest required free energy, ∆G= - 30.7
kcal/mol (figure 26). This high free energy may cause AS1 secondary structure to be very
stable and can not relax to bind to and form a complex with traM mRNA. On the other
hand, AS2 and AS3 have much lower free energy (∆G= - 9.9 kcal/mol and ∆G= - 18.4
kcal/mol, respectively) (Figure 16). These lower free energy values may allow AS2 and
AS3 secondary structure to be more flexible to relax and bind to the target traM mRNA.
Importantly, a TraM-irrelevant control did not show significant alteration in conjugation
frequency, indicating that the effects of AS2 and AS3 on LV23 conjugation proficiency
were indeed TraM-specific. Second, the different effects of AS1 on conjugation from B.
fragilis to B. fragilis and to E. coli may indicate the proficieny of conjugation from B.
fragilis to B. fragilis is distinct from that to E. coli. Our western blot in Figure 28 showed
that AS1 did suppressed TraM expression in comparison to the control. However, this
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suppression is not as strong as that caused by AS2 and AS3 (Figure 28). This data might
suggest that a certain level of TraM expression is sufficient for conjugation to occur from
B. fragilis to B. fragilis, however, it may not sufficient for conjugation to occur from B.
fragilis to E. coli.
This is the first time an antisense approach has been used to study protein function
in Bacteroides spp. Because the antisense constructs were designed to cover the
ribosomal binding site of TraM, it’s most likely that they bind to the mRNA of traM and
prevent translation of this protein. However, there is also a possibility that the AS bind to
traM mRNA and direct these transcripts to degradation process.

Figure 26. The predicted secondary structures of anti-traM AS constructs. The
predicted structures were obtained by using the Vienna RNAfold engine
(http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi).
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Although the quantitative conjugation data showed that TraM was required for
conjugation, it is needed to determine if these AS constructs were truly specific for traM
inhibition. If TraM-AS RNAs were indeed gene-specific, then TraM protein production
would be significantly reduced in the presence of traM AS molecule(s). Moreover, if the
AS molecules affected TraM expression at the transcriptional level, then both traM
mRNA transcripts and TraM protein production would be suppressed. But if the AS
RNAs affected only TraM translation, then traM mRNA transcripts would not be affected
while protein production would be greatly reduced. Thus, to determine if these AS
constructs were truly specific for traM inhibition we quantitated the production of traM
mRNA transcripts as well as the TraM protein level.

Quantitative PCR (Q-PCR) experiments to estimate the level of traM transcripts in the
presence of different antisense molecules.
The control for these studies was the B. fragilis LV23 strain that harbored the
shuttle vector containing only the cefoxitin A (cfxA) promoter (the promoter constructed
into this shuttle vector to drive the transcription of the antisense constructs). In these QPCR studies, because there was no realiable reference gene to be used in B. fragilis, even
16S rRNA, the relative expression of tetQ was used as the reference. However because
tetQ is highly upregulated in conjugation conditions, it is possible that tetQ did not
equally upregulated at the same level in different cell cultures, resulting in higher
variation in the results (Figure 27).
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Q-PCR showed that the effect of ASs on traM is independent from those on
ORF8 and/or BctA expression (Figure 27). AS1, the AS that did not impair conjugation
suppressed some traM and bctA transcripts but those effects probably were not significant
enough to affect conjugation. AS2, the most effective AS seemed significantly suppress
traM transcripts but not those of ORF8 and bctA. Our data showed that AS2 significantly
have upregulated effect on the transcript level of ORF8. However, this effect may not be
real, as discussed above, the use of tetQ as the reference gene for this Q-PCR experiment
may result in high variations among different samples. If the effect of AS2 on ORF8 was
real, an evaluation of the protein level of ORF8 is necessary to confirm this data. AS3,
the AS that suppressed conjugation up to 82% did not seem to have any effect on
transcription level. However, we do not conclude that AS3 may have effect on translation
level of traM because complex mechanisms may be involved in the regulation of the
expression of TraM.
Our results show that traM expression is indeed specifically down regulated in the
presence of AS2, and that this results in a corresponding reduction on conjugation
frequency. TraM is thus required for B. fragilis conjugation. Further, we also conclude
that the use of an antisense-RNA based option to knock-down gene expression in
Bacteroides fragilis is a viable approach, and that the nature of the construct (sequence
and size) is important for consistent and interpretable results. With the use of appropriate
controls as described above (multiple target gene AS constructs, non-target gene AS
construct, and quantitation of gene expression of genes surrounding the target gene) the
contribution of TraM to B. fragilis conjugation could be rigorously assessed.
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A) traM

B) orf8

C) bctA
Figure 27: Relative expression of A)
traM mRNA, B) ORF8 mRNA, C) bctA
mRNA in B. fragilis LV23 cells
harboring the control plasmid with the
cefoxitin

promoter

alone

or

that

carrying AS1, AS2 or AS3 construct.
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TraM protein expression in the presence of different antisense molecules.
To determine the protein expression level of TraM in the presence of different
antisense molecules, we have successfully generated specific antibodies for TraM.

Figure 28: TraM expression in the presence of AS in B. fragilis membrane fraction.
About 20 μg of total proteins of B. fragilis membrane fractions were loaded into each
lane. TM: proteins from B. fragilis conjugation deficient TM4000 strain; P: the control B.
fragilis LV 23 strain that expression the control vector pFD288P; AS1, AS2 and AS3:
LV23 strain expressing AS1, AS2 and AS3, respectively.
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Figure 28 shows expression of TraM in the membrane fraction of B. fragilis LV23
in the presences of different AS constructs. α-OpmA antibodies were used for the control
detection of a house keeping protein in the membrane, OmpA. Our data shows that TraM
is strongly associated in the membrane fraction of B. fragilis, confirming previous
findings in E. coli. Moreover, our data also confirmed that the protein expression level of
TraM was indeed significantly reduced in the presence of AS2 and AS3, explaining the
impairment of DNA transfer in the presence of these antisenses in the quantitative
conjugation experiments.
In short, these results show that TraM expression is indeed specifically down
regulated in the presence of AS2 and AS3, and that these results correspond to the
reduction in conjugation frequency. TraM is thus required for B. fragilis conjugation.

Identification of TraM’s Regions Required for Interactions with BctA and BmpH

Computer analysis of the TraM sequence revealed that some amino acids had
good probability (P=>50%) of forming coiled-coil structures under physiological
conditions – these were amino acids 47-75; 106-134; and 150-162 (COILS program
(109)). Coiled-coil domains are structural motifs commonly involved in protein-protein
interactions (109). Computer analyses of both BctA and BmpH (our putative coupling
protein and DNA relaxase, respectively) also showed several predicted coiled-coil
structures. Thus, we hypothesized that one or more predicted coiled-coil regions of TraM

120
may aid in its interaction with one or more predicted coiled-coil domains of BctA and/or
BmpH. If this is true, then a TraM mutant protein with a disrupted coiled-coil domain(s)
should be impaired in its interaction with BctA and/or BmpH, indicating that the
predicted coiled-coil regions may indeed be required for the interaction. Published data
strongly support the contention above. A predicted coiled-coil region of an E. coli
conjugation protein TrhB was shown to be essential for its interaction with the coupling
protein TraG (57). Further, a coiled-coil domain of the Coprinus cinereus Rad50 protein
was required for formation of complexes with the exonuclease Mre11; point mutations as
well as short insertions within the coiled-coil domains of Rad50 reduced or abolished
function in vivo (1, 83). For these studies (and those proposed below), the specific protein
structure conferred by the coiled-coil was exploited to study its interaction-conferring
ability. A coiled-coil region is a heptad repeat of amino acids labeled “a,b,c,d,e,f,g,”, of
which positions a and d are hydrophobic and form the helix interface that mediates
interaction with other proteins (Fig 1) (109). Mutagenesis of the amino acid at position(s)
a or d can disrupt the coiled-coil, and thus alter its interaction with another protein. One
elegant example of this particular approach is the published study identifying the
requirement of two amino acids at position a and d of a coiled coil domain of the
Neurospora sp protein FRQ for its dimerization (27). In this study, alteration of the
hydrophobic amino acid Leucine at position a or d to a hydrophilic amino acid Arginine,
weakened or abolished the intra-subunit interaction(27). Another example is the study
that identified the requirement of amino acids at position a or d within the coiled-coil
domain of the E. coli protein EspA for its oligomerization (40). Similar site directed
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mutagenesis approaches were used to identify interacting regions within a coiled-coil
domain required for oligomerization of the Enterococcus faecalis DivIVA protein (148),
and dimerization of the E. coli MukB protein, (101).

Figure 29. Coiled coil heptad amino acid
arrangement of two partner proteins.
Based on the published studies above, we hypothesized that if coiled- coil
domains were indeed required for TraM interaction with BctA/ BmpH, and if
hydrophobic amino acids at position a or d of the heptad were mutated to hydrophilic
amino acids, the coiled-coil structure would be disrupted, leading to an impairment of
protein-protein interaction(s). Usually, to determine if a coiled-coil structure is disrupted,
circular dichroism (CD) and melting temperature experiments are performed to measure
the helicity and stability of the protein (101). Since our current infrastructure does not
allow us to perform such experiments, we proposed to use site-directed mutagenesis of
multiple amino acids at position a or d of a predicted TraM coiled-coil domain, followed
by bacterial two-hybrid screens and far-western analyses to determine if those specific
TraM amino acids were required for its interaction with BctA/BmpH.
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Figure 30. TraM and predicted coiled coil regions. Green areas are
hypothetical coiled coil regions. Potential coiled coil regions are designated
as A, B, and C.

To test if an amino acid (aa) at position a or d of the three predicted coiled-coil
regions of TraM is required for its interaction with BctA or BmpH, we used site directed
mutagenesis to alter that hydrophobic amino acid to a more hydrophilic aa, in an effort to
disrupt the coiled-coil structure. Potential coiled-coil domains are designated A, B and C
(figure 30). There are 22 amino acids at positions a and d in these three predicted coiledcoil regions of TraM. The COILS program was used to identify amino acids, which when
mutated, would cause the most significant reduction in the probability of forming coiledcoils. Thus, amino acid at position F66, L69 (region A), L123 (region B) and M154
(region C) were selected for mutagenesis studies. If an amino acid of the predicted
coiled-coil region is required for the interaction, its mutants should show different
interaction strengths with BctA and/or BmpH. Mutation to a stronger hydrophobic amino
acid is expected to strengthen the interaction of TraM with its partner protein.
Conversely, mutation to a weaker hydrophobic or hydrophilic amino acid is expected to
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impair the interaction(s). The interactions of most important mutants were further
biochemically confirmed by Far western analyses. The expression of TraM mutants were
also tested by western blot, showing that they were stably expressed.

TraM’s amino acid F66 and L123 are required for interaction with BctA
Figure 31 shows the bacterial two-hybrid analysis of the interactions of different
TraM mutants with BctA. The control was the interaction of the wild type TraM with
BctA. Western blots were performed to confirm that all of the mutants were made and
stable. A western blot showing the expression of the most significant mutants was shown
in Figure 33, blot 3. The multiple bands observed in this blot are degradation products of
TraM, which were commonly observed when TraM was expressed under induction
conditions. As can be seen from Figure 31, mutations of amino acid (aa) F66 in region A
and amino acid L123 in region B significantly impaired the interaction of TraM with
BctA, while other mutations did not. As expected, alterations to amino acids of increased
hydrophilicity resulted in greater impairment of protein-protein interactions. These results
thus strongly suggest that F66 and L123 are involved in the interaction of TraM with
BctA, and that the chosen amino acids in region C are not.
Moreover, Far Western analyses of mutants F66R, L123R and L123S also
revealed significantly reduced interactions between TraM and BctA (Figure 33).
Together with the bacterial two-hybrid data presented above, there is now sufficient
evidence confirming that amino acid F66 and L123 are indeed involved in the interaction
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between TraM and BctA, and that TraM, via interaction with the coupling protein BctA,
is required for DNA transfer from B. fragilis to other bacteria.

TraM’s amino acid L123 is required for interaction with BmpH
Bacterial two hybrid analyses of TraM mutants and the relaxase BmpH as can be
seen from Figure 32 revealed that the specific TraM amino acids chosen for mutagenesis
(except one – L123S) above did not affect/alter the interaction between the two proteins.
Interestingly, the L123S mutant showed an increase up to 50% in its interaction strength
with BmpH compared to that of the white type TraM. This significant alteration suggests
that L123 may also be involved in the interaction between TraM and BmpH, but in a
manner that facilitates protein contact.
Far western experiments also confirmed the strong interaction of mutant L123S
with the relaxase BmpH. The interactions of TraM and other mutants (F66R and L123R)
with BmpH are not detectable in a far western experiment. This may be due to two
reasons. First, the interaction between TraM and BmpH may not be as strong as that with
BctA. Second, under the purification conditions used, BmpH molecules may not be fully
non-denatured, hindering its interactions with other proteins on the membrane. Even
though the amount of purified BmpH used for overlaying the blot was increased from 10
μg to 30 μg, it was still not sufficient to detect the interaction of BmpH with TraM.
The above data strongly suggest that L123 may also be involved in the interaction
between TraM and BmpH. The same amino acid may be a target for competition between
two interacting partners, the coupling protein BctA and the relaxase BmpH. If this is true,
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there may be a regulatory mechanism(s) to control the strength of interaction of TraM
with either BctA or BmpH when needed. Indeed, the lowered strength of interaction seen
with wild-type TraM and BmpH as opposed to L123S-BmpH may actually be required
for rapid DNA transfer, where interacting complexes may need to be generated and disassembled in a dynamic fashion.
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Figure 31: Bacterial two hybrid analysis of interactions of TraM mutants with BctA.
Mutants tested for region A were: F66A, F66G, F66R, L69A, L69G and L69R. In region
B, tested mutants were: L123A. L123G. L123R and L123S. In region C: tested mutants
were: M154A, M154G and M154R.

Figure 32: Bacterial two hybrid analysis of interactions of TraM mutants with
BmpH.
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Figure 33: Far western analysis of the interactions between λ-cI-TraM mutants and
BctA or BmpH. Cells: XL-1 Blue cell lysate. pBT: cell lysate of XL-1 Blue cells that
carried pBT vector alone. Wild type TraM and other mutants were expressed in pBT
vector in XL-1 Blue cells. Blot 1: Overlaid with 10 μg of natively purified 6His-BctA,
Blot 2: overlaid with 30 μg of natively 6His-BmpH, 3: Detection of λ-cI-TraM with αTraM antibodies, 4: Non-specific control blot with α-His antibodies. The multiple bands
seen in blot 3 are degradation products of TraM, which were commonly observed under
induction condition.

CHAPTER V
DISCUSSION

BctA is Essential for Conjugation from B. fragilis LV23

Although many conjugative mobile elements have been identified in Bacteroides
spp., none of the core components of the transfer regions of these elements have been
characterized in detail except BctA of BTF-37 (77). BctA of BTF-37 and its homolog
TraG (OrfG) in other Bacteroides conjugative transposon systems (B. thetaiotaomicron
CTnDOT, CTnERL and CTnXBU422) have long been predicted to be coupling proteins
of Bacteroides CA (150). All of the above proteins exhibit characteristics of coupling
proteins: they have Walker box (ATPase) motifs, a DNA binding motif, they are
associated with the membrane when expressed in E. coli (BctA of BTF-37 (77) and TraG
of CTnDOT (191)) and their expressions upregulated under conjugation conditions (BctA
of BTF-37 (77)). Furthermore, BctA has been shown to be a tetramer (77), which would
allow it to form a ring structure at the base of the membrane like other described coupling
proteins (TrwB of R388 system (58), TraD of F system (72), TraG of RP4 system (156),
and VirB4 of Ti system (115)). However, there were still not enough data to confirm that
BctA and its TraG homologs were indeed bona fide coupling proteins in Bacteroides spp.
128
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conjugation systems, since their ATPase activity was not determined, and gene knockouts were not available. In this study, we further showed that the putative coupling
protein BctA was essential for conjugation mediated by the conjugative transposon BTF37. This is another important piece of evidence to further indicate the role of a coupling
protein of BctA in B. fragilis. Experiments to investigate the requirement of BctA Walker
A and B motifs and their ATPase activities for conjugation need to be further carried out.
Moreover, it is known that the CP acts as a “gate-keeper” of the CA system. One
of its important roles is to recognize and interact with the cognate relaxosome. This is the
first step for the transfer of the relaxosome through the CA. In many conjugative systems
including the E. coli F plasmid and A. tumefaciens Ti plasmid, the coupling protein is
highly selective for the respective cognate relaxosome (73, 155). CPs of other E. coli
systems like RP4 and R388 (though less selective) still only interact with their own
cognate relaxosomes and closely related plasmids (73). In contrast, Bacteroides
conjugative transposons are known for non-selective or permissive transfer of DNA.
DNA from different bacterial origin (from E. coli or from other Bacteroides species) can
be easily transferred by Bacteroides CTns. Meanwhile, our data show that when bctA was
deleted, no transfer could occur. This result indicates that BctA is a key component to
determine the permissive characteristic of B. fragilis CA for different types of transfer
DNA (180). Although the precise molecular mechanism of relaxosome recognition by the
CP has not been fully defined, our result still indicates that Bacteroides CP is unique and
different from that of E. coli and A. tumefaciens. This non-specificity feature is the key
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for the easy and promiscuous dissemination of mobile elements carrying antibiotic
resistance genes from B. fragilis to other bacteria.

BTF37 Genes are Involved In Conjugation Process in B. fragilis LV23

To investigate the involvement of all ORFs in the known 16 kb region of BTF-37
contig, we examined the transcriptional expression of these ORFs under conjugation
conditions by RT-PCR. Our results reveal that all 11 genes are up-regulated under
conjugation induction conditions, suggesting that all known BTF-37 contig genes are
involved in the conjugation process. They are most likely predicted CA proteins. These
ORFs show similarity to respective putative conjugative genes in other Bacteroides
conjugative systems, such as B. thetaiotaomicron CTnDOT and B. vulgatus CTn34.
However, no homology has been found for these genes with conjugation genes of E. coli
or A. tumefaciens. In contrast, conjugation systems in E. coli, A. tumefaciens and even in
some other gram negative species always exhibit some homologous components (2).
Thus, the fact that B. fragilis BTF-37 CA components are not homologous to that of other
genera further strengthens the idea about the unique and distinguishing nature of
Bacteroides conjugation system. It therefore becomes all the more necessary to fully
understand the structure and molecular mechanism of Bacteroides conjugation. Only a
full understanding of the Bacteroides conjugation process can help design suitable
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interventions to inhibit the dissemination of antibiotic resistance genes from Bacteroides
spp. to other bacteria.

TraM and TraN are Identified as Components of B. fragilis CA

As a “gate-keeper” of the DNA transfer process, the CP does not just interact with
the relaxosome but also with some components of the CA. In A. tumefaciens, the CP
VirB4 has been shown to interact with other ATPases like VirD4, VirB11 and other nonATPase components of the CA like VirB8 and VirB3 (47). In E. coli R27 plasmid, a Ftype system, the CP TraGH has been shown to have interactions with TrhBH, another
multimeric protein that may form a ring structure to extend the pore of the coupling
protein into the periplasmic space (57). This CP also interacts with other CA components
like TrhEH and TrhIH (92).
In the search for CA components that interact with the CP BctA, we have found
that BctA interacts with two gene products, ORF7 (TraM) and ORF8 (TraN). In bacterial
two-hybrid analyses, BctA interacts most strongly with TraM. The interaction with TraN
is weaker. This is an early step in understanding CA protein contacts in B. fragilis. If
TraM and TraN truly interact with BctA, then they are most likely localized in the
membrane, close to BctA as well as to the base of the CA, and may be important
components of the CA. In fact, we demonstrated that TraM indeed interacts with BctA
and it is localized to the inner membrane. Further biochemical studies are required to
determine if TraN truly interacts with BctA.
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Moreover, further studies are required to find other components of CA, to
determine how they interact, and how are they are regulated to ensure complex function
of the CA. These components might be other ORFs of the 16 kb BTF-37 contig and
interact with TraM or TraN. They may be unkown ORFs in the unkown sequence of
BTF37. A bacterial two hybrid analysis for the interaction of BctA with B. fragilis LV23
genomic library will help identifying all possible interacting partners of BctA. Moreover,
a similar genomic library screening can also be carried out to identify all possible
interacting partners of TraM or TraN. In these experiments, a genomic library of B.
fragilis LV23 can be generated by purifying the strain genomic RNA and randomly
amplifying this genomic RNA with short, random nucleotide primers. This genomic
library can be randomly constructed into the target vector of the bacterial two hybrid
system and then a normal bacterial two hybrid analysis will be carried out. Any positive
colonies that show interaction with the bait (BctA, TraM or TraN) will be collected and
the putative gene that interacts with the bait will be sequenced by using specific primers
for the target vector.
An alternative approach to identify other components of the CA is to amplify the
whole BTF-37 CTn and generate a random library of BTF-37 genes by random PCR,
then perform a bacterial two hybrid library screening. It is now possible to amplify this
37 kb fragment by using specific polymerase kits for long fragment amplification from
Biorad. Another method is to use transposon insertion to generate a random library of
BTF37 CTn.
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TraM Localization, Interactions and Function in B. fragilis CA

Our bacterial two-hybrid analysis and Far Western experiments show that TraM
interacts with both the CP BctA and the relaxase BmpH; this is the first report of an
interaction between a CA component with a CP in Bacteroides spp. This is also the first
demonstration of an interaction of a CA protein other than a CP with the relaxosome (via
interaction with the relaxase).
In the A. tumefaciens Ti plasmid sytem, E. coli RP4 and F plasmid systems and in
other species, the relaxase may complex with other partners, but they are not involved in
the CA (89). For example, in the F plasmid system, the relaxase TraI interacts with
partners like IHF, TraY and TraM but none of them are core components of the CA
(142). In contrast, in A. tumefaciens, the relaxase VirD2 has not been found to have
interaction(s) with any other component of the CA other than with the CP (29). Thus, the
demonstration of the interaction of TraM, a component of the CA, with BmpH, a
relaxase, is a new finding, supporting the idea that the molecular mechanism of
conjugation in Bacteroides spp. is distinct from that of E. coli and other species.
In addition, the relaxosome of Bacteroides spp. in general requires far fewer
numbers of proteins for DNA processing than E. coli (95, 130). There are two examples
in which Bacteroides spp. relaxosomes have only one DNA processing protein. They are
BmpH of Tn5520 and MobA of Tn4555 (165, 182). Therefore, it is highly possible that
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TraM may support the direction of relaxosome complex through the mating channel by
interacting with the relaxase BmpH.
The triad nature of the interactions of TraM with BctA and/or BmpH also
suggests that TraM may act as a helper for both BmpH and BctA to facilitate movement
of the relaxosome through the CA channel. In fact, the finding that amino acids F66 and
L123 in TraM two predicted coiled-coil domains are required for interaction with BctA
indicate that TraM interaction with BctA may be important for conjugation. Moreover,
these two amino acids may be essential for TraM function in mediating DNA transfer in
B. fragilis. Further examination of the requirement of these amino acids for conjugation
in B. fragilis is required to test these hypotheses. To test these hypotheses, first, a B.
fragilis traM null mutant must be generated. Then, different TraM mutants should be
introduced for expression into the traM null mutant. Finally, quantitative conjugation
experiments will be carried out to investigate the impacts of TraM mutants on
conjugation proficiency of B. fragilis. If it is true that amino acid F66 and L123 are
required for TraM interaction with BctA and if this interaction is important for DNA
transfer, then we expect to observe a significant defect in the DNA transfer capacity of B.
fragilis in the presence of TraM mutants. In addition, it is important to determine the
regions on BctA and BmpH that are required for interaction with TraM. This can be
performed by using a mutator strain such as E. coli XL-1 Red to generate libraries of
BctA and BmpH mutants then analyse the interactions of the mutants with TraM by using
a bacterial two hybrid library screening. The mutants that show significant defect on
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interaction of BctA/ BmpH with TraM will also be further investigated for their
requirements for DNA transfer in B. fragilis.
A recent cryo-EM structure of the core conjugation complex from E. coli
pKM101 shows that the CA core complex spans from the inner to the outer membranes,
and is formed by the different components TraN/VirB7, TraO/VirB9 and TraF/VirB10
(48). The inner layer of the T4SS in A. tumefaciens was speculated to be composed of
VirB6 and VirB8 because these proteins interact directly with the transfer T-DNA (47).
Thus, in the B. fragilis conjugation system, and along with the interaction with the
relaxase BmpH and localization to the inner membrane, TraM may also be a component
of the inner ring complex like VirB6 and VirB8. An investigation by using cryo-EM or
X-ray crystallography approaches to examine the 3D structure of TraM will reveal this
speculation. Moreover, to investigation TraM possible oligomerization nature, a
molecular mass determination of TraM can be performed as previously described (77). In
this experiment, TraM will be purified under non-denature condition and then
electrophoresed under native condition. A Ferguson plot for analysis of migration ratios
of TraM possible species will be performed to calculate their molecular weights.
Moreover, the finding that the same amino acid L123 is required for TraM
interaction with both BctA and BmpH indicates a possible regulatory mechanism for
interaction of TraM with BctA or BmpH to facilitate DNA transfer efficiency in B.
fragilis. A very complicated regulatory system of many different CA proteins has been
defined in IncF plasmid (including F, R100 and pRK100) conjugation (49). In
Bacteroides spp., the regulatory cascade tetQ-rteA-rteB and rteC is responsible for
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controlling the excision of CTnDOT (122). It was thought that RteC also regulates tra
gene expression. However, recently, it has been demonstrated that the expression of
CTnDOT transfer genes is activated by the excision proteins, independent of RteC (84).
All of these reported regulatory systems suggest that the regulatory mechanism of
conjugation is complicated and that there may be more new mechanisms that need to be
explored.
Thus, we propose multiple models for a controlled regulatory system in which
TraM switches interactions between BmpH and/to BctA (Figure 34). In the first model,
model A, TraM is anchored in the inner membrane and interacts with BctA in normal
conformation. When the relaxasome heads to the CA, TraM may change conformation to
interact with BmpH first, assist the relaxasome to interact with BctA to translocate
through the CA. On the other hand, a second model, model B, would be one in which
TraM is a part of the inner ring of the CA and interacts with BctA in its normal
conformation after the CA is formed to maintain the CA ring structure. However, when
the relaxosome passes through the gate (BctA), TraM may change conformation,
allowing interaction with BmpH to assist the movement of the relaxosome. It is also
possible that multi copies of TraM may present in the actual CA structure. A 3D crystal
structure of TraM, BctA and BmpH will solve this question.
To distinguish the above proposed models, several approaches can be employed.
First, a 3D crystal structure of the whole CA complex with the presence of TraM, BctA
and BmpH may show the exact localization of TraM in this triad relationship. Second, a
time-line cryo-EM or X-ray crystallography experiment can be carried out to freeze the
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movements of the relaxosome and the conformation changes of TraM. This experiment
will show whose protein, BctA or TraM will contact with the relaxosome first. Third, the
DNA to be transferred can be radio-label and then the contact of the DNA with CA
components can be captured with time-line procedure and DNA binding assay such as
mobile shift gel electrophoresis to determine which protein will contact with the
ralaxosome first (via interaction with BmpH or the DNA).
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Model A

Model B

Figure 34. Predicted localization of TraM, model A. The red arrow shows the direction
where the relaxosome directed by BmpH will pass through during conjugation. Model A:
TraM is localized in the inner membrane and interacts with BctA in normal
conformation. When the relaxasome heads to the CA, TraM may change conformation to
interact with BmpH, assist the relaxasome to interact with BctA to translocate through the
CA. Model B: TraM, as a member of the inner ring of the CA, interacts with BctA in
normal conformation to maintain the CA ring structure. When the relaxosome passes
through the gate (after contacting with BctA), TraM may change conformation, allowing
interaction with BmpH to assist the movement of the relaxosome through the CA.
Adapted from Christie, Nature, 2009 (28).
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Furthermore, the finding that the AS1 construct showed different effects on
conjugation frequencies from B. fragilis to B. fragilis and to E. coli, suggesting that the
required conjugation machine for transfer to B. fragilis may be different for E. coli. The
fact that AS1 can suppress the transfer to E. coli up to 100% in comparison to the control,
while does not have effect on the transfer to B. fragilis, indicates that a certain level of
TraM production may be enough for transfer to occur from B. fragilis to B. fragilis. But a
much higher level of TraM production may be required for transfer from B. fragilis to E.
coli. This speculation may make sense as more energy may be required for conjugation to
occur to a different genus. An experiment in which TraM expression level can be
controlled by an induced agent may help verify this speculation. In this experiment, a B
fragilis traM null mutant must be generated. Then, TraM will be introduced into B.
fragilis via an expression vector, in which TraM expression can be controlled by an
induced agent. Under non-induction condition, there should be a leaky expression of a
small amount of TraM. However, when the induced agent is used, TraM expression is
upregulated. Quantitative conjugation of different TraM production levels will be carried
out to determine the required level of TraM for conjugation to occur to B. fragilis and to
E. coli.
In short, further investigation is required to obtain more in-depth knowledge of
the requirements of amino acids F66 and L123, and the possible regulatory relationship
of the interactions of TraM with BctA and BmpH for DNA transfer in B. fragilis. A
further mutagenesis study is required to identify the region of BctA and BmpH required
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for the interaction with TraM. Moreover, these mutants need to be examined by
quantitative conjugation in B. fragilis to confirm the requirement of these interactions for
DNA transfer in B. fragilis. Due to difficulty in genetically modifying B. fragilis
chromosomal genes, work in this dissertation did not attempt such experiments.
However, in the future, when we have the right tools, it would be informative for B.
fragilis conjugation studies to pursue this direction.

TraM is Required for Conjugation in B. fragilis and Application of Antisense RNA

By using antisense RNA tools, we further confirmed the requirement of TraM for
DNA transfer within B. fragilis and from B. fragilis to E. coli. This is the first time an
antisense RNA approach has been applied in B. fragilis to knock down expression of a
target gene to investigate its function. This method helped overcome the difficulty
encountered in generating a traditional knock-out mutant in Bacteroides spp. Previously,
antisense RNAs also have been successfully used to suppress the expression of bacterial
proteins in several studies, especially in the clostridia (118, 125, 138, 143, 177, 178),
where very similar difficulties are encountered in generating knock-out mutants. This
technology proved to be efficient and will be useful for future study in anaerobes.
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Future perspective

As the most prominent group of bacteria residing in the gut and as those that also
harbor a plethora of transmissible genetic elements carrying many antibiotic resistance
genes, Bacteroides spp. have long been considered as a reservoir for the dissemination of
antibiotic resistance traits to other bacteria. With the alarming rise and spread of
antibiotic resistance to even new generation of antibiotics, the need to prevent the
dissemination of antibiotic resistance has become more urgent. Because conjugation is
the major means for bacteria, especially Bacteroides spp., to disseminate antibiotic
resistance genes to other bacteria, effective intervention targets this process is an
appropriate approach. Currently, many groups are exploring non-antibiotic-based
methodologies to prevent conjugation-based DNA transfer (45, 51, 107, 111, 180).
Different ways to inhibit the conjugative ralaxase have been tested in laboratories.
Antibody libraries against the relaxase TrwC of conjugative plasmid R388 can be used to
block relaxase activity within recipient cells (51). Other studies report being able to
disrupt the conjugation process by using specific inhibitors to the conjugative relaxase of
the F plasmid (107). Interestingly, a short palindromic repeat (CRISPR) RNA
interference can also limit gene transfer – this has been tested in Staphylococci by
targeting relaxase genes (111). Overall, the search for better antibiotic resistance
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interventions targeting conjugation is promising. Our study provides a better
understanding of the B. fragilis conjugation system. This will be useful for the design of
appropriate drugs to intervene with the conjugation process in Bacteroides spp., and
ultimately inhibit the spread of antibiotic resistance genes from this genus to other
bacteria.

Significance

In conclusion, this study represents the first in-depth characterization of a
conjugal apparatus protein, TraM, in B. fragilis, which will be useful for future studies
aimed at developing interventions to prevent dissemination of antibiotic resistance from
Bacteroides spp. to other bacteria. This is the first demonstration of interactions of a CA
protein with a CP and a relaxase in B. fragilis. Moreover, this is one of very few studies
using RNA antisense technology to knock-down target gene expression in anaerobes,
avoiding the difficulties encountered in modifying genes in these genera.
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